Clinical Trials

• V260 Registration Study
  ClinicalTrials.gov Identifier: NCT00166517 - Active, not recruiting
  Gastrointestinal Rotavirus
  
• V260, Concomitant Use of V260 and DTacP in Healthy Infants
  ClinicalTrials.gov Identifier: NCT00258154 - Active, not recruiting
  Rotavirus Disease
  
• V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
  ClinicalTrials.gov Identifier: NCT00175513 - Recruiting
  Psychosis
  
• V501 (Gardasil) Study in Preadolescent Females
  ClinicalTrials.gov Identifier: NCT00411749 - Active, not recruiting
  Papillomavirus Infections
  
• V930 First in Man (FIM) Study
  ClinicalTrials.gov Identifier: NCT00250419 - Active, not recruiting
  Cancers Expressing HER-2 and/or CEA
  
• VA Genetic Tissue Banking
  ClinicalTrials.gov Identifier: NCT00032578 - Completed
  Tissue Banking
  
• VA HDL Intervention Trial (VA-HIT) Ancillary Study Data Analysis
  ClinicalTrials.gov Identifier: NCT00035711 - Completed
  Coronary Disease; Heart Diseases; Cardiovascular Diseases; Carotid Artery Diseases; Diabetes Mellitus, non-insulin dependent; Hypertension; ...
  
• VA Low Vision Intervention Trial
  ClinicalTrials.gov Identifier: NCT00223756 - Recruiting
  Vision, Low
  
• VA MI Plus
  ClinicalTrials.gov Identifier: NCT00126750 - Recruiting
  Myocardial Infarction; Comorbidities
  
• VA NEPHRON-D Study
  ClinicalTrials.gov Identifier: NCT00555217 - Not yet recruiting
  Type 2 Diabetes; Renal Transplant; Kidney Disease; Nephropathy; Hyperkalemia
  
• Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
  ClinicalTrials.gov Identifier: NCT00027131 - Terminated
  Breast Neoplasms
  
• Vaccination Against Melanoma and Other Cancers
  ClinicalTrials.gov Identifier: NCT00006074 - Completed
  Breast Cancer; Colorectal Cancer; Melanoma; Non Small Cell Lung Carcinoma; Sarcoma
  
• Vaccination for Middle Ear Infection
  ClinicalTrials.gov Identifier: NCT00001605 - Completed
  
  
• Vaccination for Patients With High Risk Cancers of the Blood
  ClinicalTrials.gov Identifier: NCT00433745 - Recruiting
  Myelodysplastic Syndrome; Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML)
  
• Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00487305 - Recruiting
  Follicular Lymphoma
  
• Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00116467 - Completed
  Acute Myelogenous Leukemia
  
• Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00116441 - Completed
  Multiple Myeloma
  
• Vaccination of Children Following Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00169728 - Active, not recruiting
  Allogeneic Haematopoietic Stem Cell Transplantation
  
• Vaccination of Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype
  ClinicalTrials.gov Identifier: NCT00001572 - Active, not recruiting
  B Cell Lymphoma; Follicular Lymphoma; Neoplasm
  
• Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells
  ClinicalTrials.gov Identifier: NCT00515983 - Completed
  Melanoma
  
• Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
  ClinicalTrials.gov Identifier: NCT00458536 - Recruiting
  Renal Cancer
  
• Vaccination of Patients with Stage IV Melanoma with Dendritic Cells
  ClinicalTrials.gov Identifier: NCT00125749 - Recruiting
  Stage IV metastatic melanoma
  
• Vaccination Plus Ontak in Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00515528 - Recruiting
  Melanoma
  
• Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
  ClinicalTrials.gov Identifier: NCT00140374 - Completed
  Prostate Cancer
  
• Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00279734 - Completed
  Rheumatoid Arthritis
  
• Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003279 - Active, not recruiting
  limited stage small cell lung cancer; Quality of Life
  
• Vaccination to Treat Melanoma in the Adjuvant Setting
  ClinicalTrials.gov Identifier: NCT00006287 - Completed
  Melanoma
  
• Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00317603 - Recruiting
  Breast Cancer
  
• Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00458653 - Recruiting
  Multiple Myeloma
  
• Vaccination with tetanus and KLH to assess immune responses.
  ClinicalTrials.gov Identifier: NCT00000105 - Recruiting
  Cancer
  
• Vaccination with Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens
  ClinicalTrials.gov Identifier: NCT00204516 - Not yet recruiting
  Malignant Melanoma
  
• Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients with HIV
  ClinicalTrials.gov Identifier: NCT00011011 - Completed
  HIV Infections
  
• Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00048893 - Recruiting
  Breast Neoplasms; Metastases, Neoplasm
  
• Vaccine and Combined Chemotherapy/Radiotherapy to Treat Inoperable Lung Cancer
  ClinicalTrials.gov Identifier: NCT00088725 - Recruiting
  Carcinoma; Non-Small Cell Lung
  
• Vaccine Efficacy ag Rotavirus Diarrhoea; Vaccine Given w Routine Childhood Vaccinations in Healthy African Infants
  ClinicalTrials.gov Identifier: NCT00241644 - Recruiting
  Prophylaxis Rotavirus
  
• Vaccine for Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00006491 - Completed
  Cancer
  
• Vaccine for Recurrent Urinary Tract Infections in Women
  ClinicalTrials.gov Identifier: NCT00261248 - Completed
  Recurrent Urinary Tract Infections in Women
  
• Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00420732 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Vaccine Plus Interleukin-2 in Treating Patients With Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00005949 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Plus Interleukin-2 Treatment of Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00051610 - Completed
  Melanoma
  
• Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00079157 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Vaccine Study for Surgically Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00569387 - Recruiting
  Pancreatic Cancer
  
• Vaccine study of MVA-MUC1-IL2 in patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00040170 - Terminated
  Prostatic Neoplasms
  
• Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00313508 - Recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00019084 - Completed
  Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer
  
• Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00027833 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum
  
• Vaccine Therapy and Detection of Immunologic Responses with Human Papillomavirus 16 E6 and E7 Peptides in Patients with Metastatic or Locally Advanced Cervical Cancer and Other Cancers Carrying the HPV
  ClinicalTrials.gov Identifier: NCT00001441 - Completed
  Anus Neoplasm; Cervix Neoplasm; Esophageal Neoplasm; Head and Neck Neoplasm; Papovaviridae Infection
  
• Vaccine Therapy and Detection of Immunologic Responses with Tumor Specific Mutated RAS Peptides in Adult Cancer Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00001380 - Completed
  Neoplasm
  
• Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
  ClinicalTrials.gov Identifier: NCT00006216 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; childhood thorax/respiratory cancer
  
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
  ClinicalTrials.gov Identifier: NCT00454168 - Recruiting
  Leukemia
  
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
  ClinicalTrials.gov Identifier: NCT00398138 - Recruiting
  Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Peritoneal Cavity Cancer
  
• Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00513578 - Recruiting
  Myelodysplastic Syndromes
  
• Vaccine Therapy and GM-CSF in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00313638 - Completed
  Myelodysplastic Syndromes
  
• Vaccine Therapy and GM-CSF in Treating Patients With Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00499772 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00104819 - Recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00436930 - Recruiting
  Melanoma (Skin)
  
• Vaccine Therapy and GM-CSF in Treating Patients With Stage III or Stage IV Breast Cancer or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00436254 - Recruiting
  Breast Cancer; Ovarian Cancer
  
• Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00470015 - Suspended
  Melanoma (Skin)
  
• Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00301093 - Active, not recruiting
  Leukemia
  
• Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002952 - Completed
  Stage IV Melanoma; childhood skin cancer; Recurrent Melanoma
  
• Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00031733 - Completed
  intraocular melanoma; Melanoma
  
• Vaccine Therapy and Interleukin-12 With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00064168 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy and Interleukin-2 After Combination Chemotherapy in Treating Patients With Relapsed or De Novo Stage II, Stage III, or Stage IV Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00101101 - Recruiting
  recurrent mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00054535 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IIIC or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00101166 - Recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00031564 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00101309 - Active, not recruiting
  recurrent neuroblastoma; recurrent tumors of the Ewing's family
  
• Vaccine Therapy and Interleukin-2 With or Without White Blood Cell Transplantation in Treating Patients With Recurrent Sarcomas
  ClinicalTrials.gov Identifier: NCT00019279 - Completed
  Recurrent Childhood Rhabdomyosarcoma; Extraosseous Ewing's Sarcoma/Primitive Neuroectodermal Tumor; Recurrent Ewing's Sarcoma/Primitive Neuroectodermal Tumor; Adult Rhabdomyosarcoma; Recurrent Childhood Soft Tissue Sarcoma; Alveolar Childhood Rhabdomyosarcoma; Recurrent Tumors of the Ewing's Family; Recurrent Adult Soft Tissue Sarcoma
  
• Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00032045 - Completed
  Intraocular Melanoma; Melanoma (Skin)
  
• Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00470574 - Recruiting
  Breast Cancer
  
• Vaccine Therapy and Radiation Therapy in Treating Patients With Carcinoembryonic Antigen-Positive Solid Tumors That Have Metastasized to the Liver
  ClinicalTrials.gov Identifier: NCT00085241 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Metastatic Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vaccine Therapy and Radiation to Liver Metastasis in Patients with CEA-Positive Solid Tumors
  ClinicalTrials.gov Identifier: NCT00081848 - Recruiting
  Liver Neoplasms
  
• Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00470379 - Recruiting
  Melanoma (Skin)
  
• Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00071955 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Vaccine Therapy and Sargramostim in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00091000 - Recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005630 - Completed
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage II non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer; ...
  
• Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
  ClinicalTrials.gov Identifier: NCT00069940 - Active, not recruiting
  Brain Tumor; childhood brain tumor; childhood soft tissue sarcoma; gastrointestinal stromal tumor; Muscle Cancer
  
• Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00027911 - Active, not recruiting
  adult soft tissue sarcoma; adult synovial sarcoma
  
• Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00088933 - Active, not recruiting
  Colon Cancer; Non-small cell lung cancer; Rectal Cancer; Small Cell Lung Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy Before and After Dose-Intensive Induction Chemotherapy Plus Immune-Depleting Chemotherapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00053170 - Recruiting
  Breast Cancer
  
• Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
  ClinicalTrials.gov Identifier: NCT00084383 - Completed
  stage I pancreatic cancer; stage II pancreatic cancer; duct cell adenocarcinoma of the pancreas
  
• Vaccine Therapy Combined With Interleukin-2 and Interferon alfa in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer)
  ClinicalTrials.gov Identifier: NCT00085436 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
  stage III melanoma
  
• Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006478 - Recruiting
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
  
• Vaccine Therapy for Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00008996 - Completed
  Follicular Lymphoma
  
• Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells
  ClinicalTrials.gov Identifier: NCT00186316 - Active, not recruiting
  Multiple Myeloma
  
• Vaccine Therapy for Patients with Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00052130 - Active, not recruiting
  Malignant Melanoma
  
• Vaccine Therapy for Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00052156 - Active, not recruiting
  Malignant Melanoma
  
• Vaccine Therapy in Preventing Cervical Cancer in Patients with Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00121173 - Recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion
  
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00054041 - Completed
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Vaccine Therapy in Preventing Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
  ClinicalTrials.gov Identifier: NCT00128661 - Active, not recruiting
  Cervical Cancer; high-grade squamous intraepithelial lesion
  
• Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00022035 - Completed
  childhood acute lymphoblastic leukemia in remission; Infection
  
• Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
  ClinicalTrials.gov Identifier: NCT00030823 - Active, not recruiting
  Breast Cancer; Male Breast Cancer
  
• Vaccine Therapy in Treating Patients Who Are Being Considered For a Solid Organ Transplant and Are at Risk For Post-Transplant Lymphoproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00278200 - Recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00107211 - Recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098917 - Recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00478062 - Recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00010309 - Active, not recruiting
  Stage IV Melanoma; stage II melanoma; stage III melanoma
  
• Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
  ClinicalTrials.gov Identifier: NCT00509691 - Recruiting
  Cancer
  
• Vaccine Therapy in Treating Patients Who Have Undergone Autologous Stem Cell Transplant for High-Risk Lymphoma or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00569309 - Not yet recruiting
  Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Small Intestine Cancer
  
• Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00020670 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; ...
  
• Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00100971 - Suspended
  adult acute myeloid leukemia with 11q23 (MLL) abnormalities; adult acute myeloid leukemia with inv(16)(p13;q22); ...
  
• Vaccine Therapy in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00004881 - Completed
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00004880 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00027534 - Completed
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
  
• Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00019110 - Completed
  Anal Cancer; Cervical Cancer; Esophageal Cancer; Head and Neck Cancer; Penile Cancer; Vulvar Cancer
  
• Vaccine Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005039 - Completed
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Advanced Refractory or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00075790 - Recruiting
  Lung Cancer
  
• Vaccine Therapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004156 - Active, not recruiting
  stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
  
• Vaccine Therapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00524277 - Recruiting
  Breast Cancer
  
• Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00012246 - Completed
  Gastrointestinal Cancer
  
• Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00004052 - Active, not recruiting
  relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
  
• Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00030303 - Active, not recruiting
  chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia
  
• Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00428077 - Recruiting
  Leukemia
  
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00019006 - Completed
  Recurrent Colon Cancer; Extensive Stage Small Cell Lung Cancer; Stage III Pancreatic Cancer; Stage III Rectal Cancer; Limited Stage Small Cell Lung Cancer; Recurrent Pancreatic Cancer; Recurrent Rectal Cancer; Stage III Non-Small Cell Lung Cancer; Stage I Pancreatic Cancer; Stage II Non-Small Cell Lung Cancer; Stage IVB Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Colon Cancer; Stage IVA Pancreatic Cancer
  
• Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
  ClinicalTrials.gov Identifier: NCT00033748 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases
  
• Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00023634 - Active, not recruiting
  adult brain tumor; Gastric Cancer; ovarian epithelial cancer; Prostate Cancer
  
• Vaccine Therapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00404339 - Recruiting
  Head and Neck Cancer
  
• Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019890 - Completed
  Stage IV Melanoma; Stage III Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00014131 - Recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Vaccine Therapy in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00096629 - Active, not recruiting
  recurrent renal cell cancer; stage I renal cell cancer; stage II renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00005629 - Active, not recruiting
  recurrent adult primary liver cancer; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Cancer
  ClinicalTrials.gov Identifier: NCT00022334 - Active, not recruiting
  localized resectable adult primary liver cancer; localized unresectable adult primary liver cancer; advanced adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00103142 - Recruiting
  Colon Cancer; liver metastases; Rectal Cancer
  
• Vaccine Therapy in Treating Patients With Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00068510 - Recruiting
  adult glioblastoma; adult anaplastic astrocytoma; recurrent adult brain tumor; adult giant cell glioblastoma; adult gliosarcoma; ...
  
• Vaccine Therapy in Treating Patients With Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00128583 - Active, not recruiting
  stage III melanoma
  
• Vaccine Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00003895 - Completed
  stage I melanoma; stage II melanoma; stage III melanoma
  
• Vaccine Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00003556 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00052988 - Active, not recruiting
  stage I melanoma; stage II melanoma; stage III melanoma
  
• Vaccine Therapy in Treating Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00020358 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Melanoma of the Eye
  ClinicalTrials.gov Identifier: NCT00036816 - Active, not recruiting
  ciliary body and choroid melanoma, medium/large size
  
• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003761 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00071942 - Completed
  stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00020267 - Completed
  Lung Cancer; Adult Soft Tissue Sarcoma; Colorectal Cancer; Bone Cancer; Ovarian Sarcoma; Melanoma; Colon Cancer; Rectal Cancer; Breast Cancer; Eye Cancer; Uterine Sarcoma
  
• Vaccine Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00021164 - Completed
  Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
  
• Vaccine Therapy in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00019526 - Active, not recruiting
  Kidney Cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002817 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003224 - Active, not recruiting
  Stage IV Melanoma; stage II melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003792 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00017355 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00022568 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00087373 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019734 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019994 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00334776 - Active, not recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
  ClinicalTrials.gov Identifier: NCT00020475 - Completed
  Extraocular Extension Melanoma; Recurrent Intraocular Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
  ClinicalTrials.gov Identifier: NCT00003229 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00017537 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage IV non-small cell lung cancer; unspecified adult solid tumor, protocol specific; ...
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004211 - Completed
  stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004029 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00010127 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005947 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005992 - Active, not recruiting
  stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00030693 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00019097 - Completed
  Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
  
• Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003959 - Active, not recruiting
  Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
  
• Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00361296 - Recruiting
  Myelodysplastic Syndromes
  
• Vaccine Therapy in Treating Patients With Nasopharyngeal Cancer at High Risk for Recurrence After Standard Therapy
  ClinicalTrials.gov Identifier: NCT00112541 - Active, not recruiting
  stage III nasopharyngeal cancer; stage IV nasopharyngeal cancer
  
• Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00309829 - Recruiting
  Kidney Cancer
  
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00023985 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00091273 - Active, not recruiting
  stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00066729 - Active, not recruiting
  stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer; ...
  
• Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00006041 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Vaccine Therapy in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00389610 - Recruiting
  Anorexia; Fatigue; Pain; Pancreatic Cancer; Psychosocial Effects/Treatment
  
• Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00466726 - Recruiting
  Leukemia
  
• Vaccine Therapy in Treating Patients With Primary Stage II Melanoma
  ClinicalTrials.gov Identifier: NCT00005052 - Active, not recruiting
  stage II melanoma
  
• Vaccine Therapy in Treating Patients With Progressive or Locally Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00098449 - Recruiting
  Prostate Cancer
  
• Vaccine Therapy in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00066261 - Suspended
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Vaccine Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00408590 - Recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00561756 - Recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00003977 - Completed
  stage III cervical cancer; recurrent cervical cancer; stage IB cervical cancer; stage IIB cervical cancer; stage IVB cervical cancer; ...
  
• Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019383 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00109811 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00005628 - Completed
  stage IVB adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma
  
• Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00471471 - Not yet recruiting
  Intraocular Melanoma; Malignant Conjunctival Neoplasm; Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Refractory Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00020397 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
  ClinicalTrials.gov Identifier: NCT00057915 - Completed
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002821 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00514072 - Recruiting
  Prostate Cancer
  
• Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
  
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103116 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
  ClinicalTrials.gov Identifier: NCT00003974 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; localized malignant mesothelioma; stage I non-small cell lung cancer
  
• Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00003274 - Active, not recruiting
  stage II melanoma
  
• Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That has Been Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00016133 - Completed
  stage II colon cancer; stage III colon cancer; adenocarcinoma of the colon
  
• Vaccine Therapy in Treating Patients With Stage II or Stage III Melanoma That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00045383 - Recruiting
  stage II melanoma; stage III melanoma
  
• Vaccine Therapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00112957 - Recruiting
  Fallopian Tube Cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
  
• Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer
  ClinicalTrials.gov Identifier: NCT00093548 - Completed
  adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized resectable adult primary liver cancer; ...
  
• Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00104845 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00398073 - Recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Stage IIB, Stage III, or Stage IV Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00091286 - Recruiting
  Colon Cancer; Rectal Cancer
  
• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00019929 - Completed
  Lung Cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00304096 - Recruiting
  Breast Cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00005816 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00091403 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00005633 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00005841 - Completed
  ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ...
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00053391 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00056134 - Recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085397 - Recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085488 - Completed
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00390338 - Recruiting
  Melanoma (Skin)
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00086866 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00003386 - Completed
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy
  ClinicalTrials.gov Identifier: NCT00503568 - Recruiting
  Lung Cancer
  
• Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
  ClinicalTrials.gov Identifier: NCT00227474 - Not yet recruiting
  Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
  
• Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer
  ClinicalTrials.gov Identifier: NCT00074295 - Active, not recruiting
  Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Who Have Finished First-Line Chemotherapy
  ClinicalTrials.gov Identifier: NCT00534209 - Recruiting
  Lung Cancer
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00104780 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
  ClinicalTrials.gov Identifier: NCT00074230 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00021424 - Completed
  Head and Neck Cancer; Metastatic Cancer
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00023647 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003665 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00033228 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00042783 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00126685 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00039325 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
  ClinicalTrials.gov Identifier: NCT00012064 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00005617 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00070070 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage I bladder cancer
  
• Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00004148 - Completed
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00107159 - Active, not recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003184 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003638 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00107185 - Recruiting
  high-grade childhood cerebral astrocytoma; low-grade childhood cerebral astrocytoma; recurrent childhood cerebral astrocytoma; ...
  
• Vaccine Therapy in Treating Young Patients With Newly Diagnosed Metastatic or Recurrent Ewing Sarcoma Family of Tumors, Rhabdomyosarcoma, or Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00526240 - Recruiting
  Neuroblastoma; Sarcoma
  
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00019331 - Completed
  Colorectal Cancer; Endometrial Cancer; Head and Neck Cancer; Liver Cancer; Lung Cancer; Melanoma (Skin); Pancreatic Cancer; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016146 - Active, not recruiting
  recurrent prostate cancer
  
• Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016120 - Active, not recruiting
  recurrent prostate cancer
  
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Vaccine Therapy Plus Donor Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00020306 - Active, not recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004918 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00003362 - Completed
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003222 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma
  ClinicalTrials.gov Identifier: NCT00020462 - Completed
  Lymphoma
  
• Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00019916 - Completed
  Breast Cancer; Ovarian Cancer
  
• Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
  ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
  stage III melanoma
  
• Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00006387 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; recurrent pancreatic cancer; stage IVA pancreatic cancer; Stage IV rectal cancer; ...
  
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003819 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004929 - Active, not recruiting
  recurrent prostate cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005632 - Active, not recruiting
  recurrent prostate cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00036933 - Active, not recruiting
  stage III prostate cancer; recurrent prostate cancer
  
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
  ClinicalTrials.gov Identifier: NCT00004249 - Active, not recruiting
  limited stage small cell lung cancer
  
• Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease
  ClinicalTrials.gov Identifier: NCT00003357 - Active, not recruiting
  stage I breast cancer; stage III breast cancer; stage II breast cancer
  
• Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
  ClinicalTrials.gov Identifier: NCT00006470 - Completed
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00052351 - Completed
  Breast Cancer
  
• Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00020254 - Active, not recruiting
  Prostate Cancer
  
• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004198 - Active, not recruiting
  stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
  
• Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
  ClinicalTrials.gov Identifier: NCT00005023 - Completed
  stage IV non-small cell lung cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage III ovarian epithelial cancer; ...
  
• Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00071981 - Recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00082641 - Recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer
  
• Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00003897 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003568 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With Immune Adjuvant in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00085137 - Active, not recruiting
  Recurrent Melanoma; stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093834 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vaccine Therapy with Or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118274 - Recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00450814 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00045227 - Completed
  Prostate Cancer
  
• Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00469820 - Recruiting
  Leukemia; Multiple Myeloma and Plasma Cell Neoplasm
  
• Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00093522 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003339 - Active, not recruiting
  Stage IV Melanoma; recurrent intraocular melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00303836 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00019591 - Completed
  stage III colon cancer; stage IV colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019214 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019448 - Completed
  Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019487 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019669 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019721 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00022438 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00019175 - Completed
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00004025 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Montanide ISA-51 and/or Imiquimod in Treating Patients With Melanoma That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00304057 - Recruiting
  Melanoma (Skin)
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
  ClinicalTrials.gov Identifier: NCT00089063 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ...
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00028496 - Completed
  Breast Cancer; Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; Head and Neck Cancer
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00009958 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00037037 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089193 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Vaccine Therapy with Tumor Specific Mutated P53 or Ras Peptides Alone or in Combination with Cellular Immunotherapy with Peptide Activated Lymphocytes (PAL Cells) Along with Subcutaneous IL-2
  ClinicalTrials.gov Identifier: NCT00001434 - Completed
  Breast Cancer; Colonic Neoplasm; Female Genital Neoplasm; Lung Cancer; Pancreatic Cancer
  
• Vaccine Therapy with Tumor Specific Mutated RAS Peptides and IL-2 or GM-CSF for Adult Patients with Solid Tumors
  ClinicalTrials.gov Identifier: NCT00001581 - Completed
  Colonic Neoplasm; Lung Neoplasm; Neoplasm; Pancreatic Neoplasm; Thyroid Neoplasm
  
• Vaccine Therapy with Tumor Specific Mutated VHL Peptides in Adult Cancer Patients with Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00001703 - No longer recruiting
  Renal Cell Carcinoma
  
• Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00002773 - Completed
  stage III pancreatic cancer; recurrent pancreatic cancer; stage IVB pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas; ...
  
• Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery
  ClinicalTrials.gov Identifier: NCT00091039 - Completed
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00305760 - Recruiting
  Pancreatic Cancer
  
• Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
  ClinicalTrials.gov Identifier: NCT00217373 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
  ClinicalTrials.gov Identifier: NCT00381875 - Recruiting
  Aids-Related Malignancies
  
• Vaccine Therapy, Interferon alfa, and Cyclophosphamide in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00095862 - Recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
  ClinicalTrials.gov Identifier: NCT00003125 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage III pancreatic cancer; stage IV breast cancer; stage IIIA non-small cell lung cancer; ...
  
• Vaccine Therapy, MDX-010, and GM-CSF in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124670 - Recruiting
  recurrent prostate cancer; stage IV prostate cancer
  
• Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00373217 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00266110 - Recruiting
  Breast Cancer
  
• Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00088985 - Recruiting
  recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Vaccine Treatment for Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00090480 - Terminated
  Breast Cancer
  
• Vaccine Treatment for Advanced Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00300612 - Completed
  Malignant Melanoma
  
• Vaccine Treatment for Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00069043 - Completed
  Melanoma
  
• Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00073398 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Vaccine Treatment for Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00105053 - Completed
  Prostate Cancer
  
• Vaccine Treatment for Surgically Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00255827 - Completed
  Pancreatic Cancer
  
• Vaccine Treatment in Combination with IL-2 and Treated Lymphocytes for Advanced Melanoma
  ClinicalTrials.gov Identifier: NCT00080353 - Recruiting
  Melanoma
  
• Vaccine Treatment of Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00089778 - Recruiting
  
  
• Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00258687 - Recruiting
  Sarcoma, Clear Cell; Sarcoma, Alveolar Soft Part; Renal Cell Carcinoma; Melanoma
  
• Vaccines to Treat Metastatic Carcinoma
  ClinicalTrials.gov Identifier: NCT00088413 - Recruiting
  Adenocarcinoma
  
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
  ClinicalTrials.gov Identifier: NCT00006630 - Terminated
  Healthy; Communicable Diseases
  
• Vaccinia virus vaccine (APSV) in vaccinia- naive subjects: PILOT
  ClinicalTrials.gov Identifier: NCT00038987 - Completed
  Smallpox
  
• Vacuum Suspension: Effects On Tissue Oxygenation, Activity and Fit
  ClinicalTrials.gov Identifier: NCT00117793 - Not yet recruiting
  Amputation; Traumatic Amputations; Diabetes; Leg Injuries
  
• Vagal Blocking for Obesity Control
  ClinicalTrials.gov Identifier: NCT00555958 - Enrolling by invitation
  Obesity
  
• Vagal Tone and Neonatal Abstinence Syndrome
  ClinicalTrials.gov Identifier: NCT00496951 - Recruiting
  Neonatal Abstinence Syndrome; Vagal Tone
  
• Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
  ClinicalTrials.gov Identifier: NCT00517140 - Completed
  Pregnancy; Cesarean Section; Uterine Rupture
  
• Vaginal Birth After Caesarean Section – Effect on Maternal Psychosocial Function
  ClinicalTrials.gov Identifier: NCT00294411 - Completed
  Vaginal Birth After Cesarean
  
• Vaginal Changes and Sexual Function in Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00053261 - Active, not recruiting
  sexuality and reproductive issues; stage IB cervical cancer
  
• Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
  ClinicalTrials.gov Identifier: NCT00386477 - Recruiting
  Cesarean Section; Endometritis; Surgical Wound Infection
  
• Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometriod Cancer
  ClinicalTrials.gov Identifier: NCT00542490 - Recruiting
  Surgically Staged Endometrial Cancer; Stage IIb Endometrial Cancer; Stage I-IIb Papillary Serous; Stage I-IIb Clear Cell Endometrial Cancer
  
• Vaginal Estrogen for the Treatment of Faecal Incontinence in Women
  ClinicalTrials.gov Identifier: NCT00307775 - Completed
  Fecal Incontinence
  
• Vaginal Heat Wash-Out in 4 Groups of Women (Pre- and Postmenopausal With and Without Female Sexual Arousal Disorder).
  ClinicalTrials.gov Identifier: NCT00443248 - Recruiting
  Sexual Dysfunction, Physiological
  
• Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II: A Phase II Trial
  ClinicalTrials.gov Identifier: NCT00247169 - Recruiting
  Cervical Intraepithelial Neoplasia (CIN)
  
• Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor
  ClinicalTrials.gov Identifier: NCT00536003 - Recruiting
  Preterm Delivery; Morbidity; Perinatal Mortality
  
• Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
  ClinicalTrials.gov Identifier: NCT00086177 - Active, not recruiting
  Pregnancy
  
• Vaginal Progesterone Versus Placebo in Multiple Pregnancy
  ClinicalTrials.gov Identifier: NCT00343265 - Recruiting
  Preterm Birth
  
• Vagus Nerve Stimulation in Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00294281 - Recruiting
  Fibromyalgia
  
• Valaciclovir to Prevent Transmission of Herpes Simplex Virus
  ClinicalTrials.gov Identifier: NCT00001649 - Completed
  Herpes Simplex
  
• Valacyclovir for longterm therapy of Herpes simplex encephalitis
  ClinicalTrials.gov Identifier: NCT00031486 - Recruiting
  Encephalitis, Herpes Simplex
  
• Valacyclovir in Immunocompromised Children
  ClinicalTrials.gov Identifier: NCT00059592 - Completed
  Shingles; Bone Marrow Transplantation
  
• Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00045292 - Active, not recruiting
  Cancer; Infection
  
• Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
  ClinicalTrials.gov Identifier: NCT00297011 - Active, not recruiting
  Herpes Labialis
  
• Valdecoxib in Treating Chronic Pain in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00021996 - Completed
  Pain; unspecified adult solid tumor, protocol specific
  
• VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00171132 - Completed
  Hypertension
  
• VALEO: A Post Authorization Survey, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands
  ClinicalTrials.gov Identifier: NCT00440765 - Recruiting
  Hematological Malignancy; Multiple Myeloma
  
• VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
  ClinicalTrials.gov Identifier: NCT00171067 - Completed
  Hypertension
  
• Valerian to Improve Sleep in Patients with Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00070928 - Completed
  Insomnia; Parkinson's Disease
  
• Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
  ClinicalTrials.gov Identifier: NCT00075842 - Active, not recruiting
  Sleep Disorders; unspecified adult solid tumor, protocol specific; Fatigue
  
• Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
  ClinicalTrials.gov Identifier: NCT00471991 - Completed
  Oral Contraception
  
• Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
  ClinicalTrials.gov Identifier: NCT00478465 - Active, not recruiting
  Chronic Fatigue Syndrome
  
• Valganciclovir in Patients with CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
  ClinicalTrials.gov Identifier: NCT00017784 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Valganciclovir in Prevention of CMV Reactivation Following Allo-SCT
  ClinicalTrials.gov Identifier: NCT00330018 - Recruiting
  Bone Marrow Transplantation; Cytomegalovirus
  
• Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00096538 - Recruiting
  classic Kaposi's sarcoma; recurrent Kaposi's sarcoma
  
• Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00016068 - Active, not recruiting
  Infection
  
• Valganciclovir to Reduce T Cell Activation in HIV Infection
  ClinicalTrials.gov Identifier: NCT00264290 - Recruiting
  HIV Infections; Cytomegalovirus Infections
  
• Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease
  ClinicalTrials.gov Identifier: NCT00361933 - Not yet recruiting
  Giant Lymph Node Hyperplasia
  
• VALID : VAlproate Versus LIthium in Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00264173 - Completed
  Bipolar Disorder
  
• VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-Term Hemodialysis
  ClinicalTrials.gov Identifier: NCT00171080 - Completed
  Hypertension
  
• VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00394823 - Completed
  Hypertension
  
• Validation and Exploration of Sleep and Mood Predictors
  ClinicalTrials.gov Identifier: NCT00005401 - Completed
  Sleep Apnea Syndromes; Depression; Lung Diseases; Sleep
  
• Validation and Field Test for Risk Appraisal Instruments
  ClinicalTrials.gov Identifier: NCT00005163 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Heart Disease Risk Reduction
  
• Validation in Humans of Genes Involved in Alcohol Drinking, Stress-Induced Alcohol Drinking and Relapse
  ClinicalTrials.gov Identifier: NCT00326742 - Completed
  Alcohol Drinking
  
• Validation of 18F-MISO-PET and 18F-FLT-PET
  ClinicalTrials.gov Identifier: NCT00159978 - Recruiting
  Head and Neck Neoplasms
  
• Validation of a Correction Factor for Measurement of an Accurate Ankle-Brachial Index in the Seated Position
  ClinicalTrials.gov Identifier: NCT00452309 - Completed
  Peripheral Arterial Disease
  
• Validation of a Historical Physical Activity Survey
  ClinicalTrials.gov Identifier: NCT00005414 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Validation of a Mortality Prediction Model for Acutely Decompensated Heart Failure Patients
  ClinicalTrials.gov Identifier: NCT00536367 - Active, not recruiting
  Heart Failure, Congestive
  
• Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
  ClinicalTrials.gov Identifier: NCT00478582 - Recruiting
  Anemia
  
• Validation of a Score of Predictive Factors for Complete Resection in Platinum-Sensitive Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00368420 - Recruiting
  Ovarian Cancer
  
• Validation of an Instrument to Qualitatively and Qualitatively Profile Hospitalist Workflow
  ClinicalTrials.gov Identifier: NCT00208663 - Recruiting
  Hospitalists
  
• Validation of Biomarkers of Exposure and Host Response
  ClinicalTrials.gov Identifier: NCT00468234 - Active, not recruiting
  Cigarette Smoker
  
• Validation of BIS-Monitor to 3 Groups of Newborn Childs
  ClinicalTrials.gov Identifier: NCT00136136 - Recruiting
  Behavior
  
• Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis
  ClinicalTrials.gov Identifier: NCT00184964 - Recruiting
  Carcinoma, Non Small Cell Lung
  
• Validation of Dietary Calcium Questionnaires Using Diet Records
  ClinicalTrials.gov Identifier: NCT00512733 - Active, not recruiting
  Healthy
  
• Validation of Driving Simulator to Blood Alcohol Concentration Standards for Impaired Driving
  ClinicalTrials.gov Identifier: NCT00559819 - Not yet recruiting
  Alcohol-Impaired Driving
  
• Validation of Esophageal Variceal Grading: A Comparative Study of Upper GI Endoscopy and Capsule Endoscopy
  ClinicalTrials.gov Identifier: NCT00475592 - Recruiting
  Esophageal and Gastric Varices
  
• Validation of Laser Doppler Flowimetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
  ClinicalTrials.gov Identifier: NCT00362999 - Not yet recruiting
  Allergic Rhinitis
  
• Validation of Methods to Estimate Body Fat
  ClinicalTrials.gov Identifier: NCT00205218 - Completed
  Healthy
  
• Validation of MRI Measurement of Cardiac Blood Flow
  ClinicalTrials.gov Identifier: NCT00417625 - Recruiting
  Coronary Artery Disease
  
• Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
  ClinicalTrials.gov Identifier: NCT00259272 - Recruiting
  Bipolar Disorder I or II
  
• Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)
  ClinicalTrials.gov Identifier: NCT00346775 - Completed
  Seasonal Allergic Rhinitis
  
• Validation of RDQ Questionnaire
  ClinicalTrials.gov Identifier: NCT00291746 - Completed
  Gastroesophageal Reflux
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• Validation of Serum Creatinine Dosage and Renal Clearance
  ClinicalTrials.gov Identifier: NCT00323128 - Recruiting
  Kidney Failure
  
• Validation of Severity of Illness Scoring Systems in Paediatric Intensive Care Units in Canada
  ClinicalTrials.gov Identifier: NCT00175799 - Recruiting
  Intensive Care Units, Pediatric
  
• Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa
  ClinicalTrials.gov Identifier: NCT00341393 - Completed
  HIV
  
• Validation of the ApneaLink Sleep Screener for Obstructive Sleep Apnea (OSA)
  ClinicalTrials.gov Identifier: NCT00354614 - Recruiting
  Obstructive Sleep Apnea
  
• Validation of the Gated Blood Pool SPECT: ERNA vs 3D Echo
  ClinicalTrials.gov Identifier: NCT00576186 - Recruiting
  Congestive Heart Failure; Ventricular Function, Left
  
• Validation of the San Francisco Syncope Rule
  ClinicalTrials.gov Identifier: NCT00300625 - Recruiting
  Syncope; Near Syncope
  
• Validation of the Siemens System Somatom Definition and Operating Software for Cardiac CT Studies
  ClinicalTrials.gov Identifier: NCT00481468 - Active, not recruiting
  Coronary Angiography; Chest Pain
  
• Validation of the Spanish Version of the Neck Disability Index
  ClinicalTrials.gov Identifier: NCT00349544 - Recruiting
  Neck Pain; Cervicalgia
  
• Validation of the Stardust Cardio-Respiratory Recorder
  ClinicalTrials.gov Identifier: NCT00466011 - Recruiting
  Obstructive Sleep Apnea
  
• Validation Study of Coronary CT Angiography as a Screening Tool in Asymptomatic Diabetes
  ClinicalTrials.gov Identifier: NCT00431977 - Recruiting
  Coronary Atherosclerosis; Diabetes Mellitus
  
• Validation Study of Physical Measurement of Tophi
  ClinicalTrials.gov Identifier: NCT00175006 - Completed
  Hyperuricemia; Gout
  
• Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00551278 - Recruiting
  Breast Cancer Sentinel Lymph Node Metastases
  
• Validity and Reliability in Measuring Biceps and Triceps by Using Ultrasound
  ClinicalTrials.gov Identifier: NCT00174005 - Recruiting
  Healthy
  
• Validity and Reliability in Measuring Iliotibial Tract by Using Ultrasound
  ClinicalTrials.gov Identifier: NCT00174213 - Recruiting
  Knee Injuries
  
• Validity and Reliability in Measuring the Subacromial Space by Using Ultrasound
  ClinicalTrials.gov Identifier: NCT00174018 - Completed
  Shoulder Impingement
  
• Validity of ADHD Subtypes Using Neuropsychological Measure
  ClinicalTrials.gov Identifier: NCT00494819 - Completed
  Attention-Deficit/Hyperactivity Disorder
  
• Valnoctamide in Mania
  ClinicalTrials.gov Identifier: NCT00140179 - Recruiting
  Mania; schizoaffective disorder, manic type
  
• Valopicitabine Alone and Together with Pegylated Interferon in Patients with Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
  ClinicalTrials.gov Identifier: NCT00120861 - Active, not recruiting
  Chronic Hepatitis C
  
• Valopicitabine When Administered Alone and in Combination with Interferon to Treatment-Naive Patients with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00120835 - Active, not recruiting
  Chronic Hepatitis C
  
• Valor II: The Valiant Thoracic Stent Graft System Clinical Study
  ClinicalTrials.gov Identifier: NCT00413231 - Recruiting
  Thoracic Aortic Aneurysm
  
• VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
  ClinicalTrials.gov Identifier: NCT00171015 - Completed
  Hypertension
  
• Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
  ClinicalTrials.gov Identifier: NCT00513162 - Recruiting
  Neuroectodermal Tumor; Brain Metastases
  
• Valproate Efficacy in Cocaine-Bipolar Comorbidity
  ClinicalTrials.gov Identifier: NCT00240110 - Not yet recruiting
  Bipolar Disorder; Cocaine Dependence
  
• Valproate in Dementia (VALID)
  ClinicalTrials.gov Identifier: NCT00071721 - Active, not recruiting
  Alzheimer Disease
  
• Valproate in Late Life Schizophrenia
  ClinicalTrials.gov Identifier: NCT00194025 - Completed
  Schizophrenia
  
• Valproate Response in Aggressive Autistic Adolescents
  ClinicalTrials.gov Identifier: NCT00065884 - Recruiting
  Autism
  
• Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
  Head and Neck Cancer
  
• Valproic Acid and Bevacizumab in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00530907 - Recruiting
  Advanced Cancer
  
• Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00227266 - Active, not recruiting
  Spinal Muscular Atrophy
  
• Valproic Acid and Its Effects on HIV Latent Reservoirs
  ClinicalTrials.gov Identifier: NCT00289952 - Recruiting
  HIV Infections
  
• Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
  ClinicalTrials.gov Identifier: NCT00481013 - Recruiting
  Spinal Muscular Atrophy
  
• Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00181220 - Recruiting
  Nasopharyngeal Carcinoma
  
• Valproic Acid in Treating Patients With Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00075777 - Active, not recruiting
  recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
  
• Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
  ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
  
• Valproic Acid Sodium Salt in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00431522 - Completed
  Bipolar Disorder
  
• Valproic Acid, Temozolomide, and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00313664 - Recruiting
  Brain and Central Nervous System Tumors
  
• Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
  ClinicalTrials.gov Identifier: NCT00495872 - Recruiting
  Advanced Cancer
  
• Valsartan in Cardiovascular Disease with Renal Dysfunction (The V-CARD) Study
  ClinicalTrials.gov Identifier: NCT00140790 - Recruiting
  Hypertension; Renal Dysfunction
  
• Valsartan in Elderly Isolated Systolic Hypertension (VALISH) Study
  ClinicalTrials.gov Identifier: NCT00151229 - Active, not recruiting
  Elderly; Isolated Systolic Hypertension
  
• Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
  ClinicalTrials.gov Identifier: NCT00460213 - Recruiting
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
  ClinicalTrials.gov Identifier: NCT00170989 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00273299 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
  ClinicalTrials.gov Identifier: NCT00171561 - Completed
  Hypertension
  
• Valtrex Once Daily for Viral Shedding in Herpes Simplex Virus 2 Seropositive Subjects
  ClinicalTrials.gov Identifier: NCT00116844 - Completed
  Herpes Genitalis
  
• VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
  ClinicalTrials.gov Identifier: NCT00306293 - Completed
  Genital Herpes
  
• Valuation of Quality of Life in Children With Asthma
  ClinicalTrials.gov Identifier: NCT00491101 - Not yet recruiting
  Asthma
  
• Value of Abciximab in Patients with AMI Undergoing PCI After Clopidogrel Pretreatment.
  ClinicalTrials.gov Identifier: NCT00133250 - Recruiting
  Myocardial Infarction
  
• Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction
  ClinicalTrials.gov Identifier: NCT00389116 - Recruiting
  Small Bowel Obstruction
  
• Value of Fecal Calprotectin
  ClinicalTrials.gov Identifier: NCT00577928 - Active, not recruiting
  Calprotectin; Inflammatory Bowel Disease
  
• Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors
  ClinicalTrials.gov Identifier: NCT00163176 - Recruiting
  Head and Neck Neoplasms
  
• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00568477 - Active, not recruiting
  Grafting; Renal Transplantation; Transplantation, Kidney; Chronic Allograft Nephropathy
  
• Value of Technology to Transfer Discharge Information
  ClinicalTrials.gov Identifier: NCT00101868 - Recruiting
  Patient discharge; Patient readmission; Access to information; Interprofessional relations; Continuity of patient care
  
• Value of Urodynamics Prior to Stress Incontinence Surgery
  ClinicalTrials.gov Identifier: NCT00509730 - Recruiting
  Stress Urinary Incontinence
  
• Vancomycin Concentration in Cerebrospinal Fluid During Pneumococcal Meningitis
  ClinicalTrials.gov Identifier: NCT00162578 - Completed
  Pneumococcal Meningitis; Intensive Care Unit
  
• Vancomycin Or Trimethoprim/Sulfamethoxazole for MRSA Osteomyelitis (VOTSMO)
  ClinicalTrials.gov Identifier: NCT00324922 - Recruiting
  Osteomyelitis; Staphylococcus Aureus
  
• Vancomycin Resistant Enterococci in Patients Awaiting Liver Transplantation at the University of Michigan: Prevalence, Risk Factors, Natural History and Outcome of Colonization
  ClinicalTrials.gov Identifier: NCT00005667 - Active, not recruiting
  Liver Diseases
  
• Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus
  ClinicalTrials.gov Identifier: NCT00175370 - Recruiting
  Staphylococcal Infections
  
• Vancomycin Vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
  ClinicalTrials.gov Identifier: NCT00304889 - Recruiting
  Clostridium Enterocolitis; Pseudomembranous Colitis; Antibiotic-Associated Colitis
  
• Vancomycin Vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
  ClinicalTrials.gov Identifier: NCT00304811 - Recruiting
  Staphylococcus Aureus
  
• Vanderbilt Pertussis Exposure Study
  ClinicalTrials.gov Identifier: NCT00469274 - Recruiting
  Pertussis
  
• Vanderbilt University Spasticity Management Program Evaluation Plan
  ClinicalTrials.gov Identifier: NCT00179114 - Completed
  Spasticity
  
• Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
  ClinicalTrials.gov Identifier: NCT00472017 - Recruiting
  Brain and Central Nervous System Tumors
  
• Vandetanib in Treating Patients With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00445549 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Vandetanib in Treating Patients With Von Hippel-Lindau Syndrome and Kidney Tumors
  ClinicalTrials.gov Identifier: NCT00566995 - Recruiting
  Kidney Cancer; Von Hippel-Lindau Syndrome
  
• Vandetanib in Treating Young Patients With Medullary Thyroid Cancer
  ClinicalTrials.gov Identifier: NCT00514046 - Recruiting
  Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
  
• Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00459121 - Recruiting
  Lung Cancer
  
• Vanguard Study for Head and Neck Cancer or NSCLC Patients
  ClinicalTrials.gov Identifier: NCT00352391 - Recruiting
  Head and Neck Cancer; Lung Cancer
  
• Vaporization as a Smokeless Cannabis Delivery System
  ClinicalTrials.gov Identifier: NCT00241592 - Completed
  Healthy Volunteers
  
• Vardenafil In Benign Prostate Hypertrophy
  ClinicalTrials.gov Identifier: NCT00461123 - Recruiting
  Benign Prostate Hyperplasia (BPH)
  
• Vardenafil Treatment of Erectile Dysfunction in Depressive and Non-Depressive Men (VALOR)
  ClinicalTrials.gov Identifier: NCT00470873 - Recruiting
  Male Erectile Dysfunction; Impotence
  
• Varenicline Adjunctive Treatment in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00492349 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Varenicline Effects In Schizophrenic Smokers
  ClinicalTrials.gov Identifier: NCT00548470 - Recruiting
  Schizophrenia; Tobocco Use Disorder; Nicotine Dependance
  
• Variability of Ventricular Mass, Volume and Ejection Fraction in Pediatric Cardiomyopathy Patients (a Trial Conducted by the Pediatric Heart Network)
  ClinicalTrials.gov Identifier: NCT00123071 - Active, not recruiting
  Cardiomyopathy, Congestive
  
• Variable Bolus Regimen 1-2-3
  ClinicalTrials.gov Identifier: NCT00135083 - Completed
  Diabetes Mellitus, Type 2
  
• Variation in Gene Expression in Neurofibromatosis Type 1
  ClinicalTrials.gov Identifier: NCT00111384 - Recruiting
  
  
• Variations of Hemispheric Lateralisation of Language Depending of Gender and Age.
  ClinicalTrials.gov Identifier: NCT00241306 - Active, not recruiting
  Aging
  
• Various G-CSF Regimens to Prevent Infection During Chemotherapy
  ClinicalTrials.gov Identifier: NCT00536081 - Not yet recruiting
  Breast Cancer; Chemotherapy; Febrile Neutropenia
  
• Varying Characteristics of Atherogenesis and Cardiopulmonary Bypass Inflammatory Response
  ClinicalTrials.gov Identifier: NCT00281164 - Recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Inflammation; Blood Coagulation Disorders
  
• Vascular Access Clinical Trials Data Coordinating Center
  ClinicalTrials.gov Identifier: NCT00067119 - Recruiting
  Kidney Failure
  
• Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
  ClinicalTrials.gov Identifier: NCT00504309 - Recruiting
  Moderate Hypertriglyceridemia
  
• Vascular and Metabolic Effects of Hormone Therapy Combined with L-Arginine in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00001752 - Completed
  Hypercholesterolemia; Postmenopause
  
• Vascular and Skeletal Protective Effects of Genistein in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00355953 - Terminated
  Menopause; Osteopenia
  
• Vascular Basis for the Treatment of Ischemia
  ClinicalTrials.gov Identifier: NCT00005681 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Vascular Benefits of Adding CarvedilolCR to Type2 Diabetic Patients on ACEI.
  ClinicalTrials.gov Identifier: NCT00430040 - Not yet recruiting
  Diabetes Mellitus, Type 2; Hypertension
  
• Vascular Disease--Structure/Function
  ClinicalTrials.gov Identifier: NCT00005506 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Vascular Effects of Carvedilol Vs. Metoprolol
  ClinicalTrials.gov Identifier: NCT00123604 - Completed
  Type 2 Diabetes
  
• Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00001963 - Completed
  Diabetes Mellitus; Healthy; Hypercholesterolemia; Hypertension
  
• Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00560170 - Recruiting
  Atherosclerosis
  
• Vascular Effects of Rosiglitazone Vs. Glyburide
  ClinicalTrials.gov Identifier: NCT00123643 - Completed
  Type 2 Diabetes
  
• Vascular Endothelial Growth Factor (VEGF) in Uveitis
  ClinicalTrials.gov Identifier: NCT00001738 - Completed
  Macular Edema, Cystoid; Uveitis
  
• Vascular Endothelial Growth Factor in Stage V ROP
  ClinicalTrials.gov Identifier: NCT00500396 - Completed
  Retinopathy of Prematurity
  
• Vascular Events In Noncardiac Surgery patIents cOhort evaluatioN Study (VISION)
  ClinicalTrials.gov Identifier: NCT00512109 - Not yet recruiting
  Vascular Death; Myocardial Infarction; Cardiac Arrest; Stroke
  
• Vascular Function in Adolescent, Diabetic Children
  ClinicalTrials.gov Identifier: NCT00348179 - Recruiting
  Type 1 Diabetes
  
• Vascular Function in the Framingham Third Generation
  ClinicalTrials.gov Identifier: NCT00035737 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Vascular Interaction with Age in Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00051376 - Completed
  Myocardial Infarction
  
• Vascular Intervention Project (VIP)
  ClinicalTrials.gov Identifier: NCT00236210 - Completed
  Vascular Disease; Diabetes; Hypertension; Hyperlipidemia; Obesity
  
• Vascular Pathophysiology in Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00214084 - Not yet recruiting
  Obstructive Sleep Apnea
  
• Vascular Reactivity in Diabetic Dialysis Patients.
  ClinicalTrials.gov Identifier: NCT00226902 - Recruiting
  Kidney Failure, Chronic; Dialysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
  
• Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00411333 - Recruiting
  Diabetic Retinopathy
  
• Vascular Response to Isoproterenol and β2 Adrenergic Receptor Polymorphisms
  ClinicalTrials.gov Identifier: NCT00226551 - Completed
  Coronary Disease
  
• Vascular Risk After Kidney Transplantation
  ClinicalTrials.gov Identifier: NCT00374595 - Recruiting
  Kidney Transplant
  
• Vascular Risk Progression in Normal and Diabetic Control Subjects.
  ClinicalTrials.gov Identifier: NCT00579228 - Recruiting
  Diabetes; Inflammation
  
• Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00438412 - Recruiting
  Obstructive Sleep Apnea
  
• Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.
  ClinicalTrials.gov Identifier: NCT00291993 - Completed
  Healthy; Obstructive Sleep Apnea
  
• Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea Before and After Treatment With CPAP.
  ClinicalTrials.gov Identifier: NCT00360659 - Active, not recruiting
  Obstructive Sleep Apnea
  
• Vasoactive Intestinal Peptide in COPD
  ClinicalTrials.gov Identifier: NCT00464932 - Completed
  COPD; Pulmonary Hypertension
  
• Vasoactive Peptides in Portal Pressure
  ClinicalTrials.gov Identifier: NCT00163982 - Recruiting
  Portal Hypertension
  
• Vasoconstrictors as Alternatives to Albumin after LVP (Large-Volume Paracentesis) in Cirrhosis
  ClinicalTrials.gov Identifier: NCT00108355 - Recruiting
  Cirrhosis; Ascites
  
• Vasodilation in Patients with Fabry's Disease
  ClinicalTrials.gov Identifier: NCT00001774 - Completed
  Cerebrovascular Accident; Fabry Disease; Healthy
  
• Vasodilators and Anti-Oxidant Therapy in Early ATN
  ClinicalTrials.gov Identifier: NCT00286403 - Not yet recruiting
  Acute Renal Failure
  
• Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
  ClinicalTrials.gov Identifier: NCT00163150 - Completed
  Cerebrovascular Accident; Hypercholesterolemia
  
• Vasomotoric Symptoms Study of Femoston Conti Low Dose
  ClinicalTrials.gov Identifier: NCT00251082 - Terminated
  Postmenopause
  
• Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest.
  ClinicalTrials.gov Identifier: NCT00127907 - Completed
  cardiac arrests
  
• Vasopressin in Traumatic Hemorrhagic Shock Study
  ClinicalTrials.gov Identifier: NCT00379522 - Not yet recruiting
  Shock; Hypovolemia; Hemorrhagic Shock
  
• Vasoreactivity in Carriers of Genetic Polymorphisms
  ClinicalTrials.gov Identifier: NCT00160888 - Recruiting
  Healthy
  
• Vasovist Endoleak Study
  ClinicalTrials.gov Identifier: NCT00483665 - Recruiting
  Abdominal Aortic Aneurysm
  
• Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
  ClinicalTrials.gov Identifier: NCT00174382 - Recruiting
  Dementia, Vascular; Dementia, Mixed
  
• VAST
  ClinicalTrials.gov Identifier: NCT00158912 - Completed
  Tachycardia
  
• Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00303732 - Recruiting
  Kidney Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
  
• Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00390000 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00563823 - Recruiting
  Melanoma (Skin)
  
• Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00072475 - Recruiting
  Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes
  
• Vatalanib in Treating Patients With Recurrent or Progressive Meningioma
  ClinicalTrials.gov Identifier: NCT00348790 - Recruiting
  Brain and Central Nervous System Tumors; Sarcoma
  
• VATS Lobectomy for Clinical Stage IB or II Lung Cancer
  ClinicalTrials.gov Identifier: NCT00425022 - Recruiting
  Carcinoma, Non-Small-Cell Lung; Thoracic Surgery, Video-Assisted
  
• VAWC and Mesh Mediated Fascial Traction - Prospective Study of a Novel Technique for Open Abdomen Closure
  ClinicalTrials.gov Identifier: NCT00494793 - Recruiting
  Open Abdomen; Fascial Closure
  
• VaxTeen Hepatitis B Vaccine Booster Study
  ClinicalTrials.gov Identifier: NCT00144313 - Completed
  Hepatitis
  
• VEAPS: Vitamin E Atherosclerosis Prevention Study
  ClinicalTrials.gov Identifier: NCT00114387 - Completed
  Atherosclerosis
  
• VEC-162 Study in Adult Patients With Primary Insomnia
  ClinicalTrials.gov Identifier: NCT00548340 - Recruiting
  Primary Insomnia
  
• VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
  ClinicalTrials.gov Identifier: NCT00291187 - Completed
  Insomnia
  
• Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00406939 - Recruiting
  Prostatic Neoplasms; Prostate Cancer
  
• VEGF as a Prognostic Factor for White Matter Damage in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00564161 - Not yet recruiting
  Preterm Infants With White Matter Damage; Preterm Infants Developing Normally
  
• VEGF Gene Transfer for Critical Limb Ischemia
  ClinicalTrials.gov Identifier: NCT00304837 - Active, not recruiting
  Critical Limb Ischemia; Ischemia; Leg Ulcer
  
• VEGF Gene Transfer for Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00056290 - Active, not recruiting
  Diabetic Neuropathy
  
• VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
  ClinicalTrials.gov Identifier: NCT00563121 - Completed
  Retinopathy of Prematurity
  
• VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00436501 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00390234 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Sarcoma
  
• VEGF Trap in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00369655 - Suspended
  Breast Cancer
  
• VEGF Trap in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00357760 - Not yet recruiting
  Kidney Cancer
  
• VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00407654 - Suspended
  Colorectal Cancer
  
• VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide
  ClinicalTrials.gov Identifier: NCT00369590 - Recruiting
  Brain and Central Nervous System Tumors
  
• VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00462826 - Recruiting
  Endometrial Cancer
  
• VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00450255 - Recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00407485 - Recruiting
  Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
  
• VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00036946 - Completed
  adult non-Hodgkin's lymphoma; adult solid tumor
  
• VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00045266 - Active, not recruiting
  adult non-Hodgkin's lymphoma; adult solid tumor
  
• VEGF Trap in Treating Patients With Stage II or Stage III Multiple Myeloma That Has Relapsed or Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00437034 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
  ClinicalTrials.gov Identifier: NCT00169832 - Active, not recruiting
  Diabetes; Coronary Artery Bypass Grafting
  
• VeinViewer Assisted Intravenous Catheter Placement in the Pediatric Emergency Department
  ClinicalTrials.gov Identifier: NCT00468065 - Recruiting
  Catheterization
  
• VeinViewer for Peripheral IV Placement in Children With Difficult IV Access
  ClinicalTrials.gov Identifier: NCT00357799 - Recruiting
  Catheterization, Peripheral; Phlebotomy; Pediatrics; Emergency Nursing
  
• Velafermin (CG53135-05) in Preventing Oral Mucositis in Patients Receiving Chemotherapy and/or Total-Body Irradiation Followed By An Autologous Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00124592 - Recruiting
  Cancer; Drug Toxicity; oral complications of cancer and cancer therapy; radiation toxicity
  
• Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia
  ClinicalTrials.gov Identifier: NCT00511069 - Recruiting
  Leukemia
  
• Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00441168 - Recruiting
  Multiple Myeloma
  
• Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00201877 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Velcade and Dexamethasone in Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00391157 - Active, not recruiting
  Multiple Myeloma
  
• Velcade and ICE For Patients With Relapsed Classical Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00439361 - Recruiting
  Hodgkin Lymphoma; Lymphoma
  
• VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)
  ClinicalTrials.gov Identifier: NCT00311337 - Recruiting
  Multiple Myeloma
  
• Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00337506 - Terminated
  Multiple Myeloma
  
• VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00505700 - Active, not recruiting
  Leukemia
  
• Velcade in MALT Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00373906 - Recruiting
  MALT Lymphoma
  
• VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00210392 - Recruiting
  Lymphoma, Mucosa-Associated Lymphoid Tissue
  
• VELCADE in MALT Lymphoma Pretreated With One Prior Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00210327 - Recruiting
  Lymphoma, Mucosa-Associated Lymphoid Tissue
  
• Velcade in Myelodysplastic Syndrome - Pilot Study
  ClinicalTrials.gov Identifier: NCT00440076 - Recruiting
  MDS
  
• VELCADE in Previously Treated Patients with Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma with BAC Features
  ClinicalTrials.gov Identifier: NCT00117351 - Terminated
  Carcinoma, Non-Small-Cell Lung; Adenocarcinoma, Bronchiolo-Alveolar
  
• VELCADE in Subjects with Relapsed or Refractory Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00063713 - Completed
  Mantle Cell Lymphoma
  
• VELCADE® (bortezomib) with Rituximab in Subjects with Relapsed or Refractory Indolent B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00085696 - Active, not recruiting
  B-Cell Lymphoma; Follicular Lymphoma; Marginal Lymphoma
  
• Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00116961 - Active, not recruiting
  Multiple Myeloma
  
• Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00469209 - Active, not recruiting
  Myeloma
  
• Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.
  ClinicalTrials.gov Identifier: NCT00388635 - Active, not recruiting
  Multiple Myeloma
  
• VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
  Multiple Myeloma
  
• VELCADE®, Rituximab, Cyclophosphamide, and Decadron (VRCD Regimen)
  ClinicalTrials.gov Identifier: NCT00413959 - Recruiting
  NHL
  
• VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00571493 - Recruiting
  Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma
  
• Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina
  ClinicalTrials.gov Identifier: NCT00353067 - Suspended
  Acute Coronary Syndrome
  
• Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
  ClinicalTrials.gov Identifier: NCT00105274 - Recruiting
  
  
• VENEK: Healing in Different Vein Harvesting Methods During Aortocoronary Coronary Artery Bypass Graft Surgery (CABG)
  ClinicalTrials.gov Identifier: NCT00180388 - Terminated
  Coronary Artery Disease
  
• Venlafaxine Augmentation
  ClinicalTrials.gov Identifier: NCT00253266 - Not yet recruiting
  Treatment Resistant Depression
  
• Venlafaxine for Hot Flashes After Breast Cancer
  ClinicalTrials.gov Identifier: NCT00198250 - Completed
  Breast Cancer
  
• Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals
  ClinicalTrials.gov Identifier: NCT00249483 - Active, not recruiting
  Cocaine-Related Disorders
  
• Venlafaxine Treatment for Marijuana Dependence and Depression - 1
  ClinicalTrials.gov Identifier: NCT00131456 - Recruiting
  Depression; Marijuana Abuse
  
• Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression
  ClinicalTrials.gov Identifier: NCT00188643 - Completed
  Bipolar Disorder
  
• Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women Receiving Hormone Therapy for Treatment or Prevention of Breast Cancer
  ClinicalTrials.gov Identifier: NCT00084669 - Recruiting
  Breast Cancer; Hot Flashes; Sleep Disorders
  
• Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot
  ClinicalTrials.gov Identifier: NCT00114608 - Recruiting
  Deep Vein Thrombosis; Pulmonary Embolism
  
• Venous Thromboembolism Taskforce Audit Program
  ClinicalTrials.gov Identifier: NCT00535171 - Recruiting
  Venous Thrombosis
  
• Venticute in Patients with Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment
  ClinicalTrials.gov Identifier: NCT00074906 - Recruiting
  Pneumonia
  
• Ventilator Associated Pneumonia and Late Complications of Percutaneous Tracheostomy
  ClinicalTrials.gov Identifier: NCT00184925 - Active, not recruiting
  Tracheostomy; Pneumonia
  
• Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support
  ClinicalTrials.gov Identifier: NCT00050401 - Completed
  Pneumonia
  
• Ventilatory Physiology in Children at Risk for Anxiety
  ClinicalTrials.gov Identifier: NCT00101777 - Completed
  
  
• VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial
  ClinicalTrials.gov Identifier: NCT00490347 - Recruiting
  End-Stage Heart Failure; Cardiomyopathies
  
• VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial
  ClinicalTrials.gov Identifier: NCT00483197 - Recruiting
  End-Stage Heart Failure; Cardiomyopathies
  
• VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy
  ClinicalTrials.gov Identifier: NCT00490321 - Recruiting
  End-Stage Heart Failure; Cardiomyopathies
  
• Ventricular Matrix Remodeling: Correlates and Prognosis
  ClinicalTrials.gov Identifier: NCT00021892 - Active, not recruiting
  Heart Diseases; Heart Failure, Congestive; Cardiovascular Diseases; Heart Failure
  
• Ventricular Pacing Site Selection (V-PASS)
  ClinicalTrials.gov Identifier: NCT00292383 - Not yet recruiting
  Atrioventricular Block
  
• Ventricular Shunt and Drain Infections - Timing of Reimplantation
  ClinicalTrials.gov Identifier: NCT00470132 - Recruiting
  Ventricular Shunt Infection
  
• Ventricular Size and Value Calcification Measures by Computed Tomography - Ancillary to MESA
  ClinicalTrials.gov Identifier: NCT00065780 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Arteriosclerosis
  
• Ventricular Synchrony in Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00165932 - Recruiting
  Irregular Heart Rate
  
• Ventricular Tachyarrhythmia (VT) Storm, Gene Expression in Implantable Cardioverter Defibrillator (ICD) Patients With Electrical Storm
  ClinicalTrials.gov Identifier: NCT00284453 - Recruiting
  Arrhythmias
  
• Ventricular-Vascular Coupling in Heart Failure
  ClinicalTrials.gov Identifier: NCT00207220 - Completed
  Heart Failure With Preserved Ejection Fraction
  
• Verapamil and Catamenial Epilepsy
  ClinicalTrials.gov Identifier: NCT00559169 - Not yet recruiting
  Catamenial Epilepsy
  
• Verification Study of Ciclosporin for Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00232076 - Completed
  Severe Atopic Dermatitis
  
• Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -
  ClinicalTrials.gov Identifier: NCT00229424 - Completed
  Gastroesophageal Reflux
  
• VERITAS: A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
  ClinicalTrials.gov Identifier: NCT00242580 - Active, not recruiting
  Subfoveal,; Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
  
• Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients
  ClinicalTrials.gov Identifier: NCT00254748 - Completed
  Borderline Personality Disorder
  
• Vermont Diabetes Information System
  ClinicalTrials.gov Identifier: NCT00109369 - Active, not recruiting
  Diabetes Mellitus
  
• Vermont Intervention: Effect on Joint Attention Skills Between Parents and Preterm Babies in the First Year of Life
  ClinicalTrials.gov Identifier: NCT00245843 - Recruiting
  Premature Birth
  
• Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
  ClinicalTrials.gov Identifier: NCT00526136 - Recruiting
  Atrial Fibrillation
  
• VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"
  ClinicalTrials.gov Identifier: NCT00180427 - Active, not recruiting
  Ventricular Fibrillation
  
• Vertebral Osteosynthesis in Degenerative Lumbar Stenosis With Spondylolisthesis - CLEOS Study
  ClinicalTrials.gov Identifier: NCT00252551 - Active, not recruiting
  Spondylolisthesis
  
• Vertebroplasty for the Treatment of Fractures Due to Osteoporosis
  ClinicalTrials.gov Identifier: NCT00068822 - Recruiting
  Spinal Fractures; Osteoporosis
  
• Vertical Scar Versus Inferior Pedicle Reduction Mammoplasty
  ClinicalTrials.gov Identifier: NCT00149344 - Recruiting
  breast hypertrophy
  
• VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy
  ClinicalTrials.gov Identifier: NCT00232466 - Recruiting
  Osteoporotic Vertebral Fractures.
  
• VERVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients
  ClinicalTrials.gov Identifier: NCT00561925 - Recruiting
  HIV Infections
  
• Very Early Surfactant and NCPAP for Premature Infants With RDS
  ClinicalTrials.gov Identifier: NCT00563641 - Completed
  Respiratory Distress Syndrome; Pneumothorax/Pulmonary Intersticial Emphysema; Chronic Lung Disease
  
• Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
  ClinicalTrials.gov Identifier: NCT00162708 - Completed
  Oropharynx Cancer; Oral Cancer; Hypopharynx Cancer; Larynx Cancer
  
• Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications
  ClinicalTrials.gov Identifier: NCT00528671 - Recruiting
  Mechanical Heart Valve Recipients
  
• Very Low Protein Diet and Renal Death in CKD - ERIKA Study
  ClinicalTrials.gov Identifier: NCT00323713 - Recruiting
  Chronic Renal Insufficiency
  
• Very Low Protein Diet or Dialysis in Uremic Elderly?
  ClinicalTrials.gov Identifier: NCT00388648 - Completed
  Uremia; Elderly (Aged >70); Dialysis; Low Protein Diet; Survival
  
• Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure
  ClinicalTrials.gov Identifier: NCT00416663 - Not yet recruiting
  Angina Pectoris
  
• Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia
  ClinicalTrials.gov Identifier: NCT00004367 - Completed
  Anxiety Disorder; Panic Disorder
  
• Vestibular Rehabilitation and Dizziness in Geriatric Patients
  ClinicalTrials.gov Identifier: NCT00275392 - Not yet recruiting
  Dizziness
  
• Vestibular Stimulation to Treat Hemispatial Neglect
  ClinicalTrials.gov Identifier: NCT00271388 - Not yet recruiting
  Stroke; Hemispatial Neglect
  
• Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.
  ClinicalTrials.gov Identifier: NCT00394056 - Recruiting
  Tinnitus
  
• Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes
  ClinicalTrials.gov Identifier: NCT00439816 - Completed
  Hypertension; Blood Pressure
  
• Veteran-Centered Outcomes Using Qualitative and Quantitative Methods
  ClinicalTrials.gov Identifier: NCT00333580 - Not yet recruiting
  Stroke; Spinal Cord Injury
  
• Veterans as Leaders in Understanding and Education (VALUE)
  ClinicalTrials.gov Identifier: NCT00137241 - Completed
  health literacy
  
• Veterans Integrated Service Network (VISN) 23 Lung Disease Self Management/Case Management Program
  ClinicalTrials.gov Identifier: NCT00126776 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• Veterans Walk for Health Study
  ClinicalTrials.gov Identifier: NCT00123435 - Recruiting
  Cardiovascular Diseases; Diabetes Mellitus; Obesity; Hypertension; Hyperlipidemia
  
• VETF Multicenter Phototherapy Protocol
  ClinicalTrials.gov Identifier: NCT00525395 - Recruiting
  Phototherapy; Vitiligo; Vitiligo Scoring System
  
• VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women
  ClinicalTrials.gov Identifier: NCT00453089 - Not yet recruiting
  Vaginal Atrophy; Vulvar Atrophy
  
• VHA Clinicians and Bioterror Events: Interactive Web-Based Learning
  ClinicalTrials.gov Identifier: NCT00123396 - Active, not recruiting
  Smallpox; Anthrax
  
• Viagra for the Treatment of IUGR
  ClinicalTrials.gov Identifier: NCT00347867 - Not yet recruiting
  IUGR
  
• Viagra in the Treatment of Primary Dysmenorrhea
  ClinicalTrials.gov Identifier: NCT00123162 - Recruiting
  Dysmenorrhea
  
• Viapaed Study In Children And Adolescents With Asthma
  ClinicalTrials.gov Identifier: NCT00315744 - Completed
  Asthma
  
• VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies
  ClinicalTrials.gov Identifier: NCT00294034 - Completed
  Pacemaker; Bradycardia
  
• Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00295295 - Completed
  Cerebral Palsy
  
• Vibration Response Imaging (VRI) in Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00506467 - Recruiting
  Lung Cancer
  
• Vibration Response Imaging (VRI) in Management and Evaluation in Patients With Pleural Effusion
  ClinicalTrials.gov Identifier: NCT00473291 - Recruiting
  Pleural Effusion
  
• Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure
  ClinicalTrials.gov Identifier: NCT00523094 - Recruiting
  Emphysema; Cancer
  
• Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma
  ClinicalTrials.gov Identifier: NCT00542282 - Recruiting
  Chronic Obstructive Pulmonary Disease; Asthma
  
• Vibration Response Imaging in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00495430 - Recruiting
  Healthy
  
• Vibration Therapy Effects on Muscle Firing Patterns
  ClinicalTrials.gov Identifier: NCT00510328 - Completed
  Healthy
  
• Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1)(Study P03672AM3)
  ClinicalTrials.gov Identifier: NCT00243230 - Active, not recruiting
  HIV Infections
  
• Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057)
  ClinicalTrials.gov Identifier: NCT00551330 - Recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405)
  ClinicalTrials.gov Identifier: NCT00523211 - Recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889)
  ClinicalTrials.gov Identifier: NCT00474370 - Recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)
  ClinicalTrials.gov Identifier: NCT00243568 - Terminated
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00431353 - Active, not recruiting
  Cytomegalovirus Infections
  
• VICTORIA (VIsceral Fat Reduction Assessed by CT-Scan On RImonabAnt)
  ClinicalTrials.gov Identifier: NCT00299325 - Active, not recruiting
  Metabolic Syndrome
  
• Vidaza to Restore Hormone Thx Prostate
  ClinicalTrials.gov Identifier: NCT00384839 - Recruiting
  Prostate Cancer
  
• Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel
  ClinicalTrials.gov Identifier: NCT00350155 - Completed
  Healthy Volunteers
  
• Video Support Program For Families With a Parent Newly Diagnosed With Cancer
  ClinicalTrials.gov Identifier: NCT00020553 - Active, not recruiting
  psychosocial effects/treatment
  
• Video Tool to Promote Knowledge of Syphilis as Facilitator of HIV Transmission
  ClinicalTrials.gov Identifier: NCT00553111 - Completed
  Syphilis
  
• Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
  ClinicalTrials.gov Identifier: NCT00002624 - Completed
  stage I non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; Adenocarcinoma of the Lung; Bronchoalveolar Cell Lung Cancer
  
• Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003692 - Active, not recruiting
  stage 0 non-small cell lung cancer; occult non-small cell lung cancer; stage I non-small cell lung cancer
  
• Video-Based Coping Skills Training for Caregivers
  ClinicalTrials.gov Identifier: NCT00396825 - Not yet recruiting
  Caregivers
  
• Video-Based Functional Performance and Assessment Following Stroke
  ClinicalTrials.gov Identifier: NCT00013494 - Completed
  Stroke
  
• Video-Based Intervention Study to Prevent HIV/STDs Among STD Clinic Patients
  ClinicalTrials.gov Identifier: NCT00137670 - Active, not recruiting
  HIV; Sexually Transmitted Diseases
  
• Videoendoscopic Drainage of Infected Pancreatic Collections
  ClinicalTrials.gov Identifier: NCT00061269 - Completed
  Pancreatitis, Acute Necrotizing
  
• Vienna Absolute Trial: Balloon Angioplasty Versus Stenting in the Superficial Femoral Artery
  ClinicalTrials.gov Identifier: NCT00281060 - Completed
  Atherosclerosis
  
• Vietnam Era Twin (VET) Registry
  ClinicalTrials.gov Identifier: NCT00005126 - Completed
  Cardiovascular Diseases; Blood Disease; Heart Diseases; Lung Diseases
  
• Vietnam Head Injury Study - Phase III
  ClinicalTrials.gov Identifier: NCT00132249 - Recruiting
  Traumatic Brain Injury; Penetrating head wounds; Closed Head Trauma; TBI
  
• Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00478283 - Active, not recruiting
  Breast Cancer
  
• Views of Cancer Patients Regarding Financial Conflicts of Interest
  ClinicalTrials.gov Identifier: NCT00097682 - Completed
  Neoplasms
  
• Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation
  ClinicalTrials.gov Identifier: NCT00530751 - Recruiting
  Breast Cancer
  
• Vildagliptin 100 mg Once Daily vs. Placebo as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
  ClinicalTrials.gov Identifier: NCT00494884 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00237237 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00352495 - Suspended
  Brain and Central Nervous System Tumors; Neurofibromatosis Type 1 (nf1)
  
• Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis
  ClinicalTrials.gov Identifier: NCT00215046 - Recruiting
  Multivessel Pulmonary Stenosis.
  
• Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
  ClinicalTrials.gov Identifier: NCT00003019 - Completed
  desmoid tumor
  
• Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors
  ClinicalTrials.gov Identifier: NCT00061893 - Suspended
  metastatic tumors of the Ewing's family
  
• Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079105 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma
  
• VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00431704 - Recruiting
  Metastatic Breast Cancer
  
• Vincristine and Dactinomycin With or Without Doxorubicin and Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
  ClinicalTrials.gov Identifier: NCT00352534 - Recruiting
  Kidney Cancer
  
• Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00335738 - Recruiting
  Retinoblastoma
  
• Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00245089 - Recruiting
  Sarcoma
  
• Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00245141 - Recruiting
  Sarcoma
  
• Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00075582 - Recruiting
  adult soft tissue sarcoma; embryonal childhood rhabdomyosarcoma; embryonal-botryoid childhood rhabdomyosarcoma; ...
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) With or Without ImmTher for Newly Diagnosed High Risk Ewing's Sarcoma
  ClinicalTrials.gov Identifier: NCT00038142 - Recruiting
  Ewing's Sarcoma
  
• Vincristine, Topotecan, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
  ClinicalTrials.gov Identifier: NCT00516295 - Not yet recruiting
  Sarcoma
  
• Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00450515 - Not yet recruiting
  Breast Cancer
  
• Vinflunine and Cetuximab as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00519831 - Active, not recruiting
  Lung Cancer
  
• Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00320073 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vinflunine in Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00545766 - Active, not recruiting
  Prostate Cancer
  
• Vinflunine in Patients with Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
  ClinicalTrials.gov Identifier: NCT00101608 - Completed
  Transitional Cell Carcinoma; Bladder Neoplasms; Kidney Neoplasms; Ureter Neoplasms
  
• Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00284154 - Active, not recruiting
  Carcinoma, Small Cell; Lung Cancer
  
• Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00284180 - Suspended
  Breast Neoplasms; Breast Cancer
  
• Vinorelbine (Oral) Plus Trastuzumab for 1st-Line Treatment of HER2/Neu Overexpressing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00433095 - Recruiting
  Metastatic Breast Cancer
  
• Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00309998 - Active, not recruiting
  Lung Cancer
  
• Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00075673 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Vinorelbine and Docetaxel in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00006682 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma
  ClinicalTrials.gov Identifier: NCT00403988 - Recruiting
  Breast Neoplasms
  
• Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
  ClinicalTrials.gov Identifier: NCT00002949 - Active, not recruiting
  stage III bladder cancer; stage III endometrial cancer; stage II bladder cancer; stage II cervical cancer; stage III cervical cancer; ...
  
• Vinorelbine and XR9576 to Treat Cancer
  ClinicalTrials.gov Identifier: NCT00001944 - Completed
  Breast Cancer; Cancer; Lung Cancer; Ovarian Cancer
  
• Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003447 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00026156 - Completed
  recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; large cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers
  ClinicalTrials.gov Identifier: NCT00003234 - Completed
  recurrent childhood rhabdomyosarcoma; recurrent childhood cerebral astrocytoma; recurrent childhood soft tissue sarcoma; ...
  
• Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00008333 - Completed
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Vinorelbine in Treating Older Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022152 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00540982 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006088 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vinorelbine in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003259 - Active, not recruiting
  stage IV prostate cancer
  
• Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005865 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Vinorelbine in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003828 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00215462 - Completed
  Esophageal Cancer; Gastric Cancer; Stomach Cancer
  
• Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00002583 - Active, not recruiting
  stage II non-small cell lung cancer; Quality of Life; stage I non-small cell lung cancer
  
• Vinorelbine Plus Fluorouracil in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003730 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00003622 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Vinorelbine Vs. Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00128310 - Completed
  Drug-resistant metastatic breast cancer.
  
• Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00103233 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Vinorelbine+Trastuzumab vs Docetaxel+Trastuzumab as 1. Line Treatment for HER2+ Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00430001 - Recruiting
  Metastatic Breast Neoplasm
  
• Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00079287 - Active, not recruiting
  Adenocarcinoma of the Lung; large cell lung cancer; recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; ...
  
• VIP:Vascular Imaging Project
  ClinicalTrials.gov Identifier: NCT00169910 - Recruiting
  Renal Transplantation; Cardiovascular Disease
  
• Viracept Expanded Access Program
  ClinicalTrials.gov Identifier: NCT00002165 - Completed
  HIV Infections
  
• Viral Activation Transfusion Study (VATS)
  ClinicalTrials.gov Identifier: NCT00000593 - Completed
  Acquired Immunodeficiency Syndrome; Blood Transfusion; Cytomegalovirus Infections; HIV Infections
  
• Viral and Host Factors in the Transmission and Pathogenesis of HIV
  ClinicalTrials.gov Identifier: NCT00219947 - Recruiting
  HIV Infections
  
• Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda
  ClinicalTrials.gov Identifier: NCT00342160 - Recruiting
  HIV
  
• Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
  ClinicalTrials.gov Identifier: NCT00214890 - Recruiting
  HIV Infections
  
• Viral Infection of Cells Lymphoid During the Premiere Demonstration of Child's Nephrotic Syndrome
  ClinicalTrials.gov Identifier: NCT00577525 - Recruiting
  Nephrosis, Lipoid
  
• Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
  ClinicalTrials.gov Identifier: NCT00448604 - Recruiting
  Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Virus Diseases; Lung Diseases, Obstructive
  
• Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00305383 - Active, not recruiting
  Hepatitis C, Chronic
  
• Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00412529 - Active, not recruiting
  Hepatitis B, Chronic
  
• Viral Load Determination and Biomarkers of High Risk HPV-Types in HIV-Positive Men
  ClinicalTrials.gov Identifier: NCT00365729 - Recruiting
  HIV Infections; Papillomavirus Infections; Anal Intraepithelial Neoplasia
  
• Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
  ClinicalTrials.gov Identifier: NCT00001316 - Recruiting
  HIV Infection; Viremia
  
• Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00390299 - Recruiting
  Brain and Central Nervous System Tumors
  
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination with Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
  ClinicalTrials.gov Identifier: NCT00000882 - Completed
  HIV Infections
  
• Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
  ClinicalTrials.gov Identifier: NCT00000831 - Completed
  HIV Infections
  
• Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Patients with HIV/HBV Co-Infection
  ClinicalTrials.gov Identifier: NCT00127959 - Completed
  HIV-1 infection; Hepatitis B virus infection
  
• Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease
  ClinicalTrials.gov Identifier: NCT00092222 - Recruiting
  Giant Lymph Node Hyperplasia
  
• Virtual Clinic Pacemaker Follow-up
  ClinicalTrials.gov Identifier: NCT00475124 - Recruiting
  Sick Sinus Syndrome; Heart Block; Bradycardia
  
• Virtual Colonoscopy (VC) for Primary Colorectal Screening
  ClinicalTrials.gov Identifier: NCT00204867 - Recruiting
  Colorectal Polyps
  
• Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal
  ClinicalTrials.gov Identifier: NCT00409786 - Active, not recruiting
  Obesity
  
• Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder
  ClinicalTrials.gov Identifier: NCT00364702 - Recruiting
  ADHD
  
• Virtual Reality Helmet to Test for Problems With Memory
  ClinicalTrials.gov Identifier: NCT00454454 - Recruiting
  Memory
  
• Virtual Reality Mobility Training System for Veterans With Vision Loss
  ClinicalTrials.gov Identifier: NCT00333879 - Not yet recruiting
  Blindness; Disability
  
• Virtual Reality Pain Control During Burn Wound Care
  ClinicalTrials.gov Identifier: NCT00261690 - Recruiting
  Burn
  
• Virtual Reality PE for Bus Bomb Survivors
  ClinicalTrials.gov Identifier: NCT00474305 - Not yet recruiting
  PTSD
  
• Virulence Determinants in S Aureus Bacteremia
  ClinicalTrials.gov Identifier: NCT00319826 - Recruiting
  S. Aureus Bacteremia
  
• Virus-Specific Cytotoxic T-Lymphocytes (CTLs) for Adenovirus Infection Post Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00111033 - Recruiting
  Adenovirus Infection
  
• Visceral Adiposity and CVD Risk in Women
  ClinicalTrials.gov Identifier: NCT00021879 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Diabetes Mellitus
  
• Visceral Fat, Metabolic Rate, and CHD Risk in Young Adults
  ClinicalTrials.gov Identifier: NCT00005388 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Obesity
  
• Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
  ClinicalTrials.gov Identifier: NCT00489515 - Recruiting
  Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
  
• Visibility of Lesion Characteristics With Phase Contrast Mammography
  ClinicalTrials.gov Identifier: NCT00467727 - Recruiting
  Breast Cancer
  
• VISIBLE Study (Visual Intervention Strategy Incorporating Bifocal & Long-Distance Eyewear)
  ClinicalTrials.gov Identifier: NCT00350389 - Recruiting
  Falls
  
• Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00267722 - Completed
  Crohn's Disease
  
• Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00267709 - Completed
  Crohn's Disease
  
• Visilizumab in Treating Patients With Graft-Versus-Host Disease Following Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00042744 - Active, not recruiting
  Graft Versus Host Disease
  
• Vision II: Evaluation of GALILEO Intravascular Radiotherapy System
  ClinicalTrials.gov Identifier: NCT00180583 - Completed
  Coronary Artery Disease
  
• Vision In Preschoolers Study (VIP Study)
  ClinicalTrials.gov Identifier: NCT00038753 - Recruiting
  Amblyopia; Strabismus; Refractive Error
  
• Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy
  ClinicalTrials.gov Identifier: NCT00140491 - Active, not recruiting
  Non-Arteritic Anterior Ischemic Optic Neuropathy
  
• VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients
  ClinicalTrials.gov Identifier: NCT00108563 - Completed
  Hepatitis C; Depression
  
• VISN Collaborative for Improving Hypertension Management With ATHENA-HTN
  ClinicalTrials.gov Identifier: NCT00374452 - Recruiting
  Hypertension
  
• Visual Cortex Stimulation in Patients with Amblyopia
  ClinicalTrials.gov Identifier: NCT00097162 - Completed
  Amblyopia; Anisometropic Ambyopia; Amblyopia, Suppression
  
• Visual Discomfort and Reading
  ClinicalTrials.gov Identifier: NCT00402155 - Recruiting
  Visual Fatigue
  
• Visual Field Assessment With Subjects Who Takes Lyrica or Sugar Pills
  ClinicalTrials.gov Identifier: NCT00351611 - Recruiting
  Epilepsies, Partial
  
• Visual Function and Ocular Pigmentation in Albinism
  ClinicalTrials.gov Identifier: NCT00001153 - Completed
  Albinism; Albinism, Ocular; Albinism, Oculocutaneous
  
• Visual Function Changes After Intraocular Pressure Reduction
  ClinicalTrials.gov Identifier: NCT00435058 - Completed
  Glaucoma
  
• Visual Impairment, Oscillopsia and Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00498199 - Recruiting
  Multiple Sclerosis
  
• Visual Motor Coordination
  ClinicalTrials.gov Identifier: NCT00568243 - Recruiting
  Healthy Volunteer
  
• Visual Prognosis in Non-Penetrating Corneal Blast Injuries
  ClinicalTrials.gov Identifier: NCT00414219 - Active, not recruiting
  Corneal Foreign Body Following Blast Injury
  
• Visual Stimulus and Eye Movement
  ClinicalTrials.gov Identifier: NCT00001172 - Active, not recruiting
  Healthy
  
• Visualization of the Cerebral Arterial Circulation Using Contrast-Enhanced Transcranial Ultrasound in Code Stroke Patients
  ClinicalTrials.gov Identifier: NCT00282841 - Recruiting
  Stroke
  
• Visualizing Peripheral Nerves Using Ultrasound-Guided Approach
  ClinicalTrials.gov Identifier: NCT00221949 - Recruiting
  Regional Anesthesia
  
• Visudyne® in Occult (VIO)
  ClinicalTrials.gov Identifier: NCT00121407 - Completed
  Macular Degeneration
  
• VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00317239 - Completed
  Anemia
  
• VITAL - VITamins to slow ALzheimer's disease (Homocysteine Study)
  ClinicalTrials.gov Identifier: NCT00056225 - Completed
  Alzheimer's Disease
  
• Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)
  ClinicalTrials.gov Identifier: NCT00344825 - Active, not recruiting
  B- Chronic Lymphocytic Leukemia
  
• Vitamin A and Response to Endotoxin
  ClinicalTrials.gov Identifier: NCT00168649 - Active, not recruiting
  TNF-Alfa; Endotoxin Levels
  
• Vitamin A and Very Low Birthweight Babies (VitAL)
  ClinicalTrials.gov Identifier: NCT00417404 - Recruiting
  Preterm Birth; Retinopathy of Prematurity
  
• Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study
  ClinicalTrials.gov Identifier: NCT00228254 - Completed
  Pneumonia; Diarrhea; Acute Upper Respiratory Tract Infections
  
• Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis.
  ClinicalTrials.gov Identifier: NCT00558480 - Not yet recruiting
  Latent Tuberculosis Infection
  
• Vitamin A Supplementation in Newborns Study
  ClinicalTrials.gov Identifier: NCT00114868 - Completed
  Infant, Newborn
  
• Vitamin A Supplementation in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00063596 - Active, not recruiting
  Infant, Premature
  
• Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
  ClinicalTrials.gov Identifier: NCT00168610 - Active, not recruiting
  Infant Mortality; Morbidity
  
• Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity
  ClinicalTrials.gov Identifier: NCT00168623 - Active, not recruiting
  Mortality; Morbidity
  
• Vitamin A Therapy for Tuberculosis
  ClinicalTrials.gov Identifier: NCT00057434 - Completed
  Pulmonary Tuberculosis; HIV Infections
  
• Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission
  ClinicalTrials.gov Identifier: NCT00053612 - Completed
  HIV Infections; Vitamin A Deficiency; HIV Seronegativity
  
• Vitamin A With BCG Vaccine
  ClinicalTrials.gov Identifier: NCT00168597 - Active, not recruiting
  Mortality; Morbidity
  
• Vitamin B Therapy for Hyperlactatemia
  ClinicalTrials.gov Identifier: NCT00031057 - Completed
  HIV Infections
  
• Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00208611 - Recruiting
  Parkinson's Disease
  
• Vitamin C and Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00534014 - Completed
  Atherosclerosis; Type 2 Diabetes
  
• Vitamin D 2 to Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00535158 - Not yet recruiting
  Kidney Disease; Muscle Weakness; Pain; Fractures, Bone
  
• Vitamin D Administration in the Nursing Home
  ClinicalTrials.gov Identifier: NCT00204919 - Active, not recruiting
  - Vitamin D Deficiency; - Osteoporosis
  
• Vitamin D and Blood Pressure
  ClinicalTrials.gov Identifier: NCT00459563 - Recruiting
  Hypertension
  
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00436475 - Recruiting
  Glucose Intolerance; Type 2 Diabetes Mellitus; Metabolic Syndrome
  
• Vitamin D and Carboxy PTH Fragments in Coronary Calcification
  ClinicalTrials.gov Identifier: NCT00502268 - Not yet recruiting
  Coronary Calcification; Endstage Renal Disease; Parathyroid Hormone
  
• Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00499408 - Recruiting
  Prostate Cancer
  
• Vitamin D Deficiency and Muscle Pain and/or Joint Pain in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00416715 - Recruiting
  Breast Cancer; Pain
  
• Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00279461 - Not yet recruiting
  Arthritis, Rheumatoid; Vitamin D Deficiency
  
• Vitamin D Deficiency, Insulin Resistance and FGF-23
  ClinicalTrials.gov Identifier: NCT00491322 - Recruiting
  Vitamin D Deficiency
  
• Vitamin D Deficiency: Bone Loss and Vascular Dysfunction
  ClinicalTrials.gov Identifier: NCT00235586 - Completed
  Postmenopausal Women
  
• Vitamin D Dose-Response Study to Establish Dietary Requirements in Infants.
  ClinicalTrials.gov Identifier: NCT00381914 - Recruiting
  Infants
  
• Vitamin D Effects in Overweight Patients
  ClinicalTrials.gov Identifier: NCT00493012 - Active, not recruiting
  Overweight; Obesity
  
• Vitamin D in Patients With Heart Failure
  ClinicalTrials.gov Identifier: NCT00501553 - Completed
  Heart Failure
  
• Vitamin D in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00524680 - Recruiting
  Prostate Cancer
  
• Vitamin D Levels and Vitamin D Education in Geriatric Patients
  ClinicalTrials.gov Identifier: NCT00273611 - Completed
  Vitamin D
  
• Vitamin D Metabolism and the Williams Syndrome
  ClinicalTrials.gov Identifier: NCT00013962 - Completed
  Williams Syndrome
  
• Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
  ClinicalTrials.gov Identifier: NCT00490412 - Not yet recruiting
  HIV Infections
  
• Vitamin D Status of Pregnant Women and Their Children in Eau Claire, South Carolina
  ClinicalTrials.gov Identifier: NCT00412087 - Recruiting
  Vitamin D Deficiency; Pregnancy
  
• Vitamin D Supplementation in Older Women
  ClinicalTrials.gov Identifier: NCT00472823 - Recruiting
  Osteoporosis; Aging
  
• Vitamin D Supplementation to Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00400491 - Recruiting
  Type 2 Diabetes
  
• Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
  ClinicalTrials.gov Identifier: NCT00418587 - Recruiting
  Systemic Lupus Erythematosus
  
• Vitamin D to Slow Progression of Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00306774 - Active, not recruiting
  Osteoarthritis, Knee
  
• Vitamin D/Calcium Polyp Prevention Study
  ClinicalTrials.gov Identifier: NCT00153816 - Recruiting
  Colorectal Cancer; Polyps; Adenomas
  
• Vitamin E and Male Infertility
  ClinicalTrials.gov Identifier: NCT00178516 - Active, not recruiting
  Male Infertility
  
• Vitamin E and Namenda (Memantine) for the Treatment of Patients With Mild to Moderate Alzheimer''s Disease on Aricept (Donepezil)
  ClinicalTrials.gov Identifier: NCT00235716 - Recruiting
  Alzheimer''s Disease
  
• Vitamin E and Pentoxifylline in Treating Women With Lymphedema After Radiation Therapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022204 - Active, not recruiting
  stage I breast cancer; Male Breast Cancer; stage IIIA breast cancer; stage II breast cancer; Quality of Life; Lymphedema
  
• Vitamin E in Aging Persons With Down Syndrome
  ClinicalTrials.gov Identifier: NCT00056329 - Active, not recruiting
  Down Syndrome; Alzheimer Disease
  
• Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00363129 - Active, not recruiting
  Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003599 - Active, not recruiting
  Lung Cancer; prevention of lung cancer
  
• Vitamin E to Prevent Mucositis in Children With Cancer
  ClinicalTrials.gov Identifier: NCT00311116 - Completed
  Cancer
  
• Vitamin E to Treat Uveitis-Associated Macular Edema
  ClinicalTrials.gov Identifier: NCT00021645 - Completed
  Cystoid Macular Edema; Uveitis
  
• Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
  ClinicalTrials.gov Identifier: NCT00064194 - Active, not recruiting
  Prostate Cancer
  
• Vitamin K and Bone Turnover in Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00062595 - Completed
  Osteoporosis
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Vitamin K Supplementation in Post-Menopausal Osteopenia
  ClinicalTrials.gov Identifier: NCT00150969 - Active, not recruiting
  Post-Menopausal Osteoporosis; Post-Menopausal Osteopenia
  
• Vitamin Metabolism in Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257439 - Not yet recruiting
  Kidney Failure
  
• Vitamin Replacement in Abetalipoproteinemia
  ClinicalTrials.gov Identifier: NCT00004574 - Completed
  Abetalipoproteinemia
  
• Vitamin therapy for prevention of stroke
  ClinicalTrials.gov Identifier: NCT00004734 - Completed
  Stroke; Cerebral Infarction; Myocardial Infarction
  
• Vitamin-D and Crohn´s Disease.
  ClinicalTrials.gov Identifier: NCT00132184 - Active, not recruiting
  Crohn Disease
  
• Vitamins and Minerals for Children With Downs Syndrome
  ClinicalTrials.gov Identifier: NCT00378456 - Completed
  Trisiomy 21 (Down Syndrome)
  
• Vitamins E & C Therapy in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00362518 - Active, not recruiting
  Diabetes
  
• Vitamins, Breastmilk HIV Shedding, and Child Health
  ClinicalTrials.gov Identifier: NCT00197756 - Active, not recruiting
  Maternal and Child Health Outcomes
  
• VITATOPS: A Study of VITAmins TO Prevent Stroke
  ClinicalTrials.gov Identifier: NCT00097669 - Recruiting
  Stroke; Transient Ischemic Attack
  
• Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00571142 - Recruiting
  * Diffuse Diabetic Macular Edema
  
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
  ClinicalTrials.gov Identifier: NCT00314990 - Completed
  Deep-Vein Thrombosis; Pulmonary Embolism
  
• VivaGel™ in Healthy Young Women
  ClinicalTrials.gov Identifier: NCT00331032 - Recruiting
  Herpes Simplex II
  
• ViVEXX Carotid Revascularization Trial (VIVA)
  ClinicalTrials.gov Identifier: NCT00417963 - Active, not recruiting
  Extracranial Carotid Artery Stenosis
  
• VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
  ClinicalTrials.gov Identifier: NCT00512005 - Not yet recruiting
  Mitral Valve Regurgitation; Left Ventricular Dysfunction; Heart Failure; Mitral Insufficiency; Mitral Incompetence; Ischemic Heart Disease
  
• Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders
  ClinicalTrials.gov Identifier: NCT00537745 - Recruiting
  Alcohol Consumption
  
• VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors
  ClinicalTrials.gov Identifier: NCT00065793 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent
  
• VMS Progesterone Study
  ClinicalTrials.gov Identifier: NCT00152438 - Recruiting
  Vasomotor symptoms; Menopause
  
• VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Prior Therapy
  ClinicalTrials.gov Identifier: NCT00004216 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• VNP20009 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006254 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00070538 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00516282 - Recruiting
  Brain and Central Nervous System Tumors
  
• VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00354276 - Recruiting
  Leukemia
  
• VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00083187 - Active, not recruiting
  adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• VNP40101M in Treating Patients With Advanced or Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00049699 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00025129 - Completed
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00049686 - Active, not recruiting
  acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; Hairy Cell Leukemia; myelodysplastic and myeloproliferative disease; ...
  
• VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00282022 - Recruiting
  Lung Cancer
  
• VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00304005 - Active, not recruiting
  Leukemia; Lymphoma
  
• VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00098761 - Active, not recruiting
  childhood brain tumor; childhood meningioma
  
• Voice Therapy for Teachers with Voice Problems
  ClinicalTrials.gov Identifier: NCT00222937 - Recruiting
  Phonotrauma
  
• Volatile Anesthetics in Cardiac Protection
  ClinicalTrials.gov Identifier: NCT00364637 - Recruiting
  Anesthesia
  
• Volitional Swallowing in Stroke Patients With Chronic Dysphagia
  ClinicalTrials.gov Identifier: NCT00306501 - Recruiting
  Stroke; Dysphagia
  
• Volociximab and Dacarbazine in Treating Patients With Unresectable Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00109915 - Recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00278187 - Active, not recruiting
  Lung Cancer
  
• Volociximab in Combination with DTIC in Patients with Metastatic Melanoma Not Previously Treated with Chemotherapy
  ClinicalTrials.gov Identifier: NCT00099970 - Completed
  Melanoma; Metastases
  
• Volociximab in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00103077 - Recruiting
  recurrent renal cell cancer; renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Volume Deficit Prior to Minor and Medium Sized Surgery and During Epidural Anaesthesia
  ClinicalTrials.gov Identifier: NCT00380107 - Recruiting
  Hypovolemia
  
• Volumetric Analysis in the Assessment of Therapy Response by CT
  ClinicalTrials.gov Identifier: NCT00582751 - Recruiting
  Multiple Diseases
  
• Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
  ClinicalTrials.gov Identifier: NCT00084045 - Active, not recruiting
  HIV Infections
  
• Von Hippel-Lindau Disease Genetic Epidemiology Study
  ClinicalTrials.gov Identifier: NCT00001803 - No longer recruiting
  Hippel Lindau Disease
  
• Voraxaze for Delayed Methotrexate Clearance
  ClinicalTrials.gov Identifier: NCT00424645 - Recruiting
  Hematologic Malignancy; Solid Tumor
  
• Voriconazole and Bronchopulmonary Aspergillosis
  ClinicalTrials.gov Identifier: NCT00159822 - Active, not recruiting
  Aspergillosis, Allergic Bronchopulmonary
  
• Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
  ClinicalTrials.gov Identifier: NCT00238355 - Recruiting
  Infection; Unspecified Adult Solid Tumor, Protocol Specific
  
• Voriconazole as Prophylactic Therapy in Lung Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00455364 - Not yet recruiting
  Infection
  
• Voriconazole as Prophylaxis for Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00177788 - Recruiting
  Fungemia; Mycoses
  
• Voriconazole Blood Levels and Toxicity
  ClinicalTrials.gov Identifier: NCT00359541 - Recruiting
  Pharmacology
  
• Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00079222 - Active, not recruiting
  Cancer; Infection
  
• Voriconazole for the Secondary Prophylaxis If Invasive Fungal Infections in Patients with Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00143312 - Recruiting
  Leukemia, Lymphocytic, Acute, L1
  
• Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
  ClinicalTrials.gov Identifier: NCT00066599 - Completed
  Cancer; Neutropenia
  
• Voriconazole Prophylaxis
  ClinicalTrials.gov Identifier: NCT00152594 - Terminated
  Leukemia, Myelocytic, Acute
  
• Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00177827 - Completed
  Post Lung Transplantation
  
• Voriconazole to Prevent Systemic Fungal Infections in Children
  ClinicalTrials.gov Identifier: NCT00005912 - Completed
  Aspergillosis; Candidiasis; Fungal diseases; Mycoses
  
• Voriconazole to Treat Fungal Infections
  ClinicalTrials.gov Identifier: NCT00001940 - Completed
  Mycoses
  
• Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
  ClinicalTrials.gov Identifier: NCT00289991 - Recruiting
  Antibiotic Prophylaxis
  
• Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00001646 - Completed
  Acquired Immunodeficiency Syndrome; Aspergillosis; HIV Infections; Immunologic Deficiency Syndromes; Neutropenia
  
• Voriconazole With or Without Interferon gamma in Treating Patients With Aspergillosis or Other Fungal Infections
  ClinicalTrials.gov Identifier: NCT00059878 - Completed
  Infection; unspecified adult solid tumor, protocol specific
  
• Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma
  ClinicalTrials.gov Identifier: NCT00561418 - Recruiting
  Lymphoma; Small Intestine Cancer
  
• Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00336063 - Recruiting
  Head and Neck Cancer; Lymphoma
  
• Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00392353 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00324870 - Recruiting
  Kidney Cancer
  
• Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00227513 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00310024 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin''s Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00275080 - Recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Adult Non-Hodgkin''s Lymphoma; Adult Solid Tumor; Chronic Myelogenous Leukemia
  
• Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00357708 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00331955 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vorinostat and Flavopiridol in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00324480 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00243100 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00331513 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00324740 - Recruiting
  Kidney Cancer
  
• Vorinostat and IV 5FU/LV in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00336141 - Recruiting
  Colorectal Cancer
  
• Vorinostat and Palliative Radiotherapy
  ClinicalTrials.gov Identifier: NCT00455351 - Recruiting
  Pelvic Cancer; Radiotherapy
  
• Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00268385 - Recruiting
  Adult Anaplastic Astrocytoma; Adult Anaplastic Oligodendroglioma; Adult Brain Tumor; Adult Glioblastoma; Mixed Gliomas
  
• Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00258349 - Suspended
  Recurrent Breast Cancer; Stage IV Breast Cancer; Male Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
  
• Vorinostat in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00305773 - Suspended
  Leukemia; Myelodysplastic Syndromes
  
• Vorinostat in Treating Patients With Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00278395 - Recruiting
  Kidney Cancer
  
• Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00363883 - Recruiting
  Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
  
• Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00499811 - Recruiting
  Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00330161 - Active, not recruiting
  Prostate Cancer
  
• Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00238303 - Recruiting
  Brain and Central Nervous System Tumors
  
• Vorinostat in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00253630 - Recruiting
  Lymphoma
  
• Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00262834 - Recruiting
  Breast Cancer
  
• Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
  ClinicalTrials.gov Identifier: NCT00217412 - Recruiting
  Brain and Central Nervous System Tumors; Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00357305 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00537121 - Recruiting
  Esophageal Cancer; Gastric Cancer; Liver Cancer
  
• Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme (GBM)
  ClinicalTrials.gov Identifier: NCT00555399 - Recruiting
  Glioblastoma Multiforme; Anaplastic Glioma
  
• Vorinostat, Paclitaxel, and Bevacizumab in Treating Patients With Metastatic Breast Cancer and/or Breast Cancer That Has Recurred in the Chest Wall and Cannot be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00368875 - Recruiting
  Breast Cancer
  
• Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00287937 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vouchers Vs. Prizes for Cocaine-Dependent Methadone Patients - 2
  ClinicalTrials.gov Identifier: NCT00249535 - Not yet recruiting
  Contingency Management
  
• Vouchers Vs. Prizes for Methadone Patients - 1
  ClinicalTrials.gov Identifier: NCT00249522 - Recruiting
  Contingency Management
  
• VP3: Vancouver Primary Prevention Program (Anxiety Disorders Prevention in School Children)
  ClinicalTrials.gov Identifier: NCT00247754 - Completed
  Anxiety
  
• VRC 008: A Phase I Clinical Trial of a Prime-Boost HIV-1 Vaccination Schedule: Multiclade DNA Vaccine, VRC-HIVDNA016-00-VP, Followed by Multiclade Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00109629 - Active, not recruiting
  
  
• VRH Pain Reduction During Burn Wound Care and Physical Therapy
  ClinicalTrials.gov Identifier: NCT00260221 - Recruiting
  Burn
  
• VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness
  ClinicalTrials.gov Identifier: NCT00467441 - Completed
  Excessive Somnolence
  
• VSL#3 Treatment in Children With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00367705 - Not yet recruiting
  Crohn's Disease
  
• VSL#3 Versus Placebo in Maintenance of Remission in Crohn''s Disease
  ClinicalTrials.gov Identifier: NCT00114465 - Recruiting
  Crohn''s Disease
  
• VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
  ClinicalTrials.gov Identifier: NCT00320476 - Recruiting
  Multiple Myeloma
  
• VTE Prophylaxis in Medically Ill Patients
  ClinicalTrials.gov Identifier: NCT00571649 - Not yet recruiting
  Venous Thromboembolism
  
• Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.
  ClinicalTrials.gov Identifier: NCT00044603 - Active, not recruiting
  Pregnancy
  
• Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine
  ClinicalTrials.gov Identifier: NCT00276068 - Completed
  Vulvar Disease
  
• VX-680, an Aurora Kinase Inhibitor, in Patients with Relapsed/Refractory Leukemia
  ClinicalTrials.gov Identifier: NCT00111683 - Suspended
  Myelogenous Leukemia, Acute; Lymphocytic Leukemia, B Cell, Acute; Myelodysplastic Syndromes; Myelogenous Leukemia, Chronic
  
• VX-710, Doxorubicin, and Vincristine in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003847 - Active, not recruiting
  intermediate type small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
  ClinicalTrials.gov Identifier: NCT00004030 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• VX-950 and Peginterferon for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00251199 - Completed
  Hepatitis C
  
• VX-950-TiDP24-C208: An Open-Label Study of Telaprevir Administered Every 12 or Every 8 Hours in Combination With Standard Treatment in Treatment naïve Patients With Chronic Genotype 1 Hepatitis C
  ClinicalTrials.gov Identifier: NCT00528528 - Recruiting
  Telaprevir; Hepatitis C, Chronic
  
• VX-950-TiDP24-C209: A Phase 2a Partially Blinded Clinical Study to Evaluate the Viral Kinetics and Safety of Telaprevir in Patients With Genotype 2 or 3 Infection.
  ClinicalTrials.gov Identifier: NCT00561015 - Not yet recruiting
  Hepatitis C, Chronic
  
• VX-950-TiDP24-C210: A Study to Assess the Activity of Telaprevir on Hepatitis C Virus in Treatment naïve Patients Who Are Chronically Infected With Hepatitis C Genotype 4 Infection
  ClinicalTrials.gov Identifier: NCT00580801 - Recruiting
  Hepatitis C, Chronic
  
• Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10mg or 20mg) in Patients With Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00442897 - Recruiting
  Hypercholesterolemia
  
• Vytorin Treating Uncontrolled Lipids (VyTUL) Study
  ClinicalTrials.gov Identifier: NCT00395603 - Terminated
  Cardiovascular Diseases; Diabetes Mellitus
  
• VZV PCR Sampling Validation Study
  ClinicalTrials.gov Identifier: NCT00501670 - Recruiting
  Herpes Zoster (Shingles)